File size: 48,971 Bytes
b4e65c0
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668
669
670
671
672
673
674
675
676
677
678
679
680
681
682
683
684
685
686
687
688
689
690
691
692
693
694
695
696
697
698
699
700
701
702
703
704
705
706
707
708
709
710
711
712
713
714
715
716
717
718
719
720
721
722
723
724
725
726
727
728
729
730
731
732
733
734
735
736
737
738
739
740
741
742
743
744
745
746
747
748
749
750
751
752
753
754
755
756
757
758
759
760
761
762
763
764
765
766
767
768
769
770
771
772
773
774
775
776
777
778
779
780
781
782
783
784
785
786
787
788
789
790
791
792
793
794
795
796
797
798
799
800
801
802
803
804
805
806
807
808
809
810
811
812
813
814
815
816
817
818
819
820
821
822
823
824
825
826
827
828
829
830
831
832
833
834
835
836
837
838
839
840
841
842
843
844
845
846
847
848
849
850
851
852
853
854
855
856
857
858
859
860
861
862
863
864
865
866
867
868
869
870
871
872
873
874
875
876
877
878
879
880
881
882
883
884
885
886
887
888
889
890
891
892
893
894
895
896
897
898
899
900
901
902
903
904
905
906
907
908
909
910
911
912
913
914
915
916
917
918
919
920
921
922
923
924
925
926
927
928
929
930
931
932
933
934
935
936
937
938
939
940
941
942
943
944
945
946
947
948
949
950
951
952
953
954
955
956
957
958
959
960
961
962
963
964
965
966
967
968
969
970
971
972
973
974
975
976
977
978
979
980
981
982
983
984
985
986
987
988
989
990
991
992
993
994
995
996
997
998
999
1000
1001
1002
1003
1004
1005
1006
1007
1008
1009
1010
1011
1012
1013
1014
1015
1016
1017
1018
1019
1020
1021
1022
1023
1024
1025
1026
1027
1028
1029
1030
1031
1032
1033
1034
1035
1036
1037
1038
1039
1040
1041
1042
1043
1044
1045
1046
1047
1048
1049
1050
1051
1052
1053
1054
1055
1056
1057
1058
1059
1060
1061
1062
1063
1064
1065
1066
1067
1068
1069
1070
1071
1072
1073
1074
1075
1076
1077
1078
1079
1080
1081
1082
1083
1084
1085
1086
1087
1088
1089
1090
1091
1092
1093
1094
1095
1096
1097
1098
1099
1100
1101
1102
1103
1104
1105
1106
1107
1108
1109
1110
1111
1112
1113
1114
1115
1116
1117
1118
1119
1120
1121
1122
1123
1124
1125
1126
1127
1128
1129
1130
1131
1132
1133
1134
1135
1136
1137
1138
1139
1140
1141
1142
1143
1144
1145
1146
1147
1148
1149
1150
1151
1152
1153
1154
1155
1156
1157
1158
1159
1160
1161
1162
1163
1164
1165
1166
1167
1168
1169
1170
1171
1172
1173
1174
1175
1176
1177
1178
1179
1180
1181
1182
1183
1184
1185
1186
1187
1188
1189
1190
1191
1192
1193
1194
1195
1196
1197
1198
1199
1200
1201
1202
1203
1204
1205
1206
1207
1208
1209
1210
1211
1212
1213
1214
1215
1216
1217
1218
1219
1220
1221
1222
1223
1224
1225
1226
1227
1228
1229
1230
1231
1232
1233
1234
1235
1236
1237
1238
1239
1240
1241
1242
1243
1244
1245
1246
1247
1248
1249
1250
1251
1252
1253
1254
1255
1256
1257
1258
1259
1260
1261
1262
1263
1264
1265
1266
1267
1268
1269
1270
1271
1272
1273
1274
1275
1276
1277
1278
1279
1280
1281
1282
1283
1284
1285
1286
1287
1288
1289
1290
1291
1292
1293
1294
1295
1296
1297
1298
1299
1300
1301
1302
1303
1304
1305
1306
1307
1308
1309
1310
1311
1312
1313
1314
1315
1316
1317
1318
1319
1320
1321
1322
1323
1324
1325
1326
1327
1328
1329
1330
1331
1332
1333
1334
1335
1336
1337
1338
1339
1340
1341
1342
1343
1344
1345
1346
1347
1348
1349
1350
1351
1352
1353
1354
1355
1356
1357
1358
1359
1360
1361
1362
1363
1364
1365
1366
1367
1368
1369
1370
1371
1372
1373
1374
1375
1376
1377
1378
1379
1380
1381
1382
1383
1384
1385
1386
1387
1388
1389
1390
1391
1392
1393
1394
1395
1396
1397
1398
1399
1400
1401
1402
1403
1404
1405
1406
1407
1408
1409
1410
1411
1412
1413
1414
1415
1416
1417
1418
1419
1420
1421
1422
1423
1424
1425
1426
1427
1428
1429
1430
1431
1432
1433
1434
1435
1436
1437
1438
1439
1440
1441
1442
1443
1444
1445
1446
1447
1448
1449
1450
1451
1452
1453
1454
1455
1456
1457
1458
1459
1460
1461
1462
1463
1464
1465
1466
1467
1468
1469
1470
1471
1472
1473
1474
1475
1476
1477
1478
1479
1480
1481
1482
1483
1484
1485
1486
1487
1488
1489
1490
1491
1492
1493
1494
1495
1496
1497
1498
1499
1500
1501
1502
1503
1504
1505
1506
1507
1508
1509
1510
1511
1512
1513
1514
1515
1516
1517
1518
1519
1520
1521
1522
1523
1524
1525
1526
1527
1528
1529
1530
1531
1532
1533
1534
1535
1536
1537
1538
1539
1540
1541
1542
1543
1544
1545
1546
1547
1548
1549
1550
1551
1552
1553
1554
1555
1556
1557
1558
1559
1560
1561
1562
1563
1564
1565
1566
1567
1568
1569
1570
1571
1572
1573
1574
1575
1576
1577
1578
1579
1580
1581
1582
1583
1584
1585
1586
1587
1588
1589
1590
1591
1592
1593
1594
1595
1596
1597
1598
1599
1600
1601
1602
1603
1604
1605
1606
1607
1608
1609
1610
1611
1612
1613
1614
1615
1616
1617
1618
1619
1620
1621
1622
1623
1624
1625
1626
1627
1628
1629
1630
1631
1632
1633
1634
1635
1636
1637
1638
1639
1640
1641
1642
1643
1644
1645
1646
1647
1648
1649
1650
1651
1652
1653
1654
1655
1656
1657
1658
1659
1660
1661
1662
1663
1664
1665
1666
1667
1668
1669
1670
1671
1672
1673
1674
1675
1676
1677
1678
1679
1680
1681
1682
1683
1684
1685
1686
1687
1688
1689
1690
1691
1692
1693
1694
1695
1696
1697
1698
1699
1700
1701
1702
1703
1704
1705
1706
1707
1708
1709
1710
1711
1712
1713
1714
1715
1716
1717
1718
1719
1720
1721
1722
1723
1724
1725
1726
1727
1728
1729
1730
1731
1732
1733
1734
1735
1736
1737
1738
1739
1740
1741
1742
1743
1744
1745
1746
1747
1748
1749
1750
1751
1752
1753
1754
1755
1756
1757
1758
1759
1760
1761
1762
1763
1764
1765
1766
1767
1768
1769
1770
1771
1772
1773
1774
1775
1776
1777
1778
1779
1780
1781
1782
1783
1784
1785
1786
1787
1788
1789
1790
1791
1792
1793
1794
1795
1796
1797
1798
1799
1800
1801
1802
1803
1804
1805
1806
1807
1808
1809
1810
1811
1812
1813
1814
1815
1816
1817
1818
1819
1820
1821
1822
1823
1824
1825
1826
1827
1828
1829
1830
1831
1832
1833
1834
1835
1836
1837
1838
1839
1840
1841
1842
1843
1844
1845
1846
1847
1848
1849
1850
1851
1852
1853
1854
1855
1856
1857
1858
1859
1860
1861
1862
1863
1864
1865
1866
1867
1868
1869
1870
1871
1872
1873
1874
1875
1876
1877
1878
1879
1880
1881
1882
1883
1884
1885
1886
1887
1888
1889
1890
1891
1892
1893
1894
1895
1896
1897
1898
1899
1900
1901
1902
1903
1904
1905
1906
1907
1908
1909
1910
1911
1912
1913
1914
1915
1916
1917
1918
1919
1920
1921
1922
1923
1924
1925
1926
1927
1928
1929
1930
1931
1932
1933
1934
1935
1936
1937
1938
1939
1940
1941
1942
1943
1944
1945
1946
1947
1948
1949
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1
00:00:01,580 --> 00:00:06,500
ุจุณู… ุงู„ู„ู‡ ุงู„ุฑุญู…ู† ุงู„ุฑุญูŠู… ุนู†ูˆุงู† ู…ุญุงุถุฑุชู†ุง ุงู„ูŠูˆู…

2
00:00:06,500 --> 00:00:13,180
autoimmunity and disease  ุงู„ู€ autoimmunity ู‡ูˆ ุนุจุฑ

3
00:00:13,180 --> 00:00:16,540
ุฃู†ุญุงุก ู„ู…ุฑุถูŠุฉ ุชู†ุดุฃ ูŠูˆู… ู…ุง ูŠุตูŠุฑ ููŠู‡ breakdown of 

4
00:00:16,540 --> 00:00:17,360
self tolerance

5
00:00:24,590 --> 00:00:28,070
ุงู„ู€ .. ุทุจุนุง ุงู„ู€ consequences of autoimmune disease

6
00:00:28,070 --> 00:00:31,570
ุจุชุนุชู…ุฏ ุนู„ู‰ ุฌุฏุด ุตุงุฑ ููŠู‡ ุฎู„ุงู„ ููŠ ุงู„ู€ self-tolerance

7
00:00:31,570 --> 00:00:34,970
ุงู„ู…ูุฑูˆุถ

8
00:00:34,970 --> 00:00:38,950
ุฃู†ู‡ ู‚ุจู„ ู…ุง ู†ุจุฏุฃ ู†ูุฑู‚ ู…ุง ุจูŠู† ู…ุตุทู„ุญูŠู† ุจูŠู† autoimmune

9
00:00:38,950 --> 00:00:41,390
response ูˆ autoimmune disease ุทุจุนุง ุงู„ู€ autoimmune

10
00:00:41,390 --> 00:00:43,890
disease ุนู… ู†ุญูƒูŠ ุนู†ู‡ุง ุฅู† ุดุงุก ุงู„ู„ู‡ autoimmune

11
00:00:43,890 --> 00:00:47,090
response ุจุชุนู†ูŠ ุฃู† ููŠ recognition of self-antigen

12
00:01:04,800 --> 00:01:11,660
ู…ุฑุฉ ุชุงู†ูŠุฉ ู†ุจุฏุฃ ุจุณู… ุงู„ู„ู‡ ุงู„ูŠูˆู… ู…ุญุงุถุฑุชู†ุง ุจุนู†ูˆุงู†

13
00:01:11,660 --> 00:01:15,880
autoimmunity and disease ุงู„ู€ autoimmune disease ู‡ูŠ

14
00:01:15,880 --> 00:01:20,470
ุชุนุฑูŠูุง ู‡ูŠ ุนุจุงุฑุฉ ุนู† breakdown of self tolerance ูˆ

15
00:01:20,470 --> 00:01:25,010
ุชุจุนุงุช ู‡ุฐู‡ ุงู„ุญุงู„ุงุช ุงู„ู…ุฑุถูŠุฉ ุจุชุนุชู…ุฏ ุฌุฏุด ุตุงุฑ ููŠู‡ ุฎู„ู„

16
00:01:25,010 --> 00:01:29,130
ููŠ ุงู„ู€ self-tolerance ูˆุจุงู„ุชุงู„ูŠ ุจูŠุตูŠุฑ ููŠ severity of

17
00:01:29,130 --> 00:01:33,590
disease ููŠ

18
00:01:33,590 --> 00:01:38,450
ุงู„ุจุฏุงูŠุฉ ู‚ุจู„ ู…ุง ู†ุจุฏุฃ ููŠ ู‡ุฐุง ุงู„ู…ูˆุถูˆุน ุจุณ ุจุฏู†ุง ู†ูุฑู‚ ู…ุง

19
00:01:38,450 --> 00:01:42,870
ุจูŠู† two terms ูˆุงุญุฏ ุงู„ู„ูŠ ู‡ูˆ ุงู„ู€ autoimmune response

20
00:01:42,870 --> 00:01:45,590
ูˆ autoimmune disease autoimmune disease ุฅู† ุดุงุก

21
00:01:45,590 --> 00:01:48,790
ุงู„ู„ู‡ ู‡ู†ุญูƒูŠ ููŠู‡ุง ุงู„ุชูุตูŠู„ ุฏู‡ ุงู„ู€ autoimmune responses

22
00:01:49,300 --> 00:01:54,240
ุจุชุนู†ูŠ ุฃู†ู‡ ููŠ recognition of self-antigen ุฃุฏู‰ ุฅู„ู‰

23
00:01:54,240 --> 00:01:59,540
pathological consequences ูˆุจุงู„ุชุงู„ูŠ ู…ู† ุฎู„ุงู„ ุงู„ุฅูุฑุงุฒ

24
00:01:59,540 --> 00:02:02,940
ุทุจุนุง ุชูƒูˆูŠู† ุงู…ุง antibody ุฃูˆ complement activation

25
00:02:02,940 --> 00:02:06,880
ุฃูˆ immune complexes formation and cell-mediated

26
00:02:06,880 --> 00:02:07,460
immunity

27
00:02:13,700 --> 00:02:19,640
causes of autoimmune disease ุทุจุนุง ุฃุดู‡ุฑ ู‡ุฐู‡ ุงู„ุฃุณุจุงุจ

28
00:02:19,640 --> 00:02:23,400
ู‡ูˆ ุงู„ู€ genetic susceptibility ูˆ ุทุจุนุง ู„ุงุญุธูˆู‡ุง ู…ู†

29
00:02:23,400 --> 00:02:26,900
ุฎู„ุงู„ ุงู„ู€ high incidence of autoimmune disease ููŠ ุงู„ู€

30
00:02:26,900 --> 00:02:31,840
monozygotic twins ูˆ ุทุจุนุง ููŠ ู†ุณุจุฉ ุฃู‚ู„ ููŠ ุงู„ู€ izygotic

31
00:02:31,840 --> 00:02:37,870
and among family member ุฅู„ุง ุฃู†ู‡ ู‡ุฐู‡ ุธุงู‡ุฑุฉ ู…ูˆุฌูˆุฏุฉ ูˆ

32
00:02:37,870 --> 00:02:42,190
ุจู†ุนุฑู ูƒุชูŠุฑ ู…ู† ุงู„ุญุงู„ุงุช ุงู„ู…ุฑุถูŠุฉ ู…ุดู‡ูˆุฑุฉ ููŠ ูƒุซูŠุฑ ู…ู†

33
00:02:42,190 --> 00:02:49,850
ุนุงุฆู„ุงุช ุงู„ุจู„ุฏ ุทุจุนุง ู‡ุฐุง ุจูŠุชุนู„ู‚ ููŠ ุงู„ู€ mode of

34
00:02:49,850 --> 00:02:54,830
inheritance generally ูˆ ู„ุงุญุธูˆุง ุฃู† ุงู„ู…ูˆุถูˆุน ู…ุด ู…ูˆุถูˆุน

35
00:02:54,830 --> 00:02:58,730
gene ูˆุงุญุฏ ูˆุฅู†ู…ุง ุนุจุงุฑุฉ ุนู† polygenic ุจู…ุนู†ู‰ ุฃู† ููŠ

36
00:02:58,730 --> 00:03:06,550
ุฃูƒุซุฑ ู…ู† individual gene has to be illicited to

37
00:03:06,550 --> 00:03:10,930
form a disease ู…ู†

38
00:03:10,930 --> 00:03:13,790
ุฃุดู‡ุฑ ุงู„ุฌูŠู†ุงุช ุงู„ู„ูŠ ู…ุฑุชุจุทุฉ ุจุงู„ู€ autoimmune disease

39
00:03:13,790 --> 00:03:18,130
ุงู„ู€ HLA complexes ูˆุทุจุนุง

40
00:03:18,130 --> 00:03:20,590
ู„ู‡ ุนู„ุงู‚ุฉ ู…ุจุงุดุฑุฉ ูƒุชูŠุฑ ู…ู† ุงู„ุฃู…ุฑุงุถ ุงู„ู„ูŠ ู‡ูŠ ุนู„ุงู‚ุฉ

41
00:03:20,590 --> 00:03:24,410
ู…ุจุงุดุฑุฉ ุจุงู„ุงู…ุณูŠ ุงู„ู„ูŠู„ ุงู„ู„ูŠ

42
00:03:26,380 --> 00:03:31,800
ู…ุฑุชุจุท ุจุญุงู„ุงุช ู…ุฑุถูŠุฉ ู…ุนูŠู†ุฉ ู„ูƒู† ู‡ุฐุง ุงู„ู‚ู„ูŠู„ ูˆุฌูˆุฏู‡

43
00:03:31,800 --> 00:03:34,960
ุจูŠุณุชู„ุฒู…

44
00:03:34,960 --> 00:03:39,460
it require other gene to cooperate ุฃูˆ

45
00:03:39,460 --> 00:03:43,660
environmental triggers ู…ุงุดูŠ ูŠุนู†ูŠ ูˆุฌูˆุฏ ุงู„ู€ gene

46
00:03:43,660 --> 00:03:48,600
ุงู„ู‚ู„ูŠู„ ู‡ุฐุง ุนู†ุฏ ุฃูŠ ุดุฎุต ู…ุนู†ุงุชู‡ ุฃู†ู‡ ุนู†ุฏู‡ high

47
00:03:48,600 --> 00:03:53,620
incidence of this disease ู„ูƒู† to become a patient

48
00:03:53,620 --> 00:03:54,800
he has

49
00:04:03,740 --> 00:04:08,600
ุนุดุงู† ูŠุณูŠุฑ ููŠ ุญุฏ ู‡ูˆ ุงู„ู€ autoimmune disease ุทุจุนุง

50
00:04:08,600 --> 00:04:14,780
ุงู„ุฏุฑุงุณุงุช ุนู„ู‰ ุงู„ู€ mice ุงุซุจุชุช ุฃู† HLA gene can

51
00:04:14,780 --> 00:04:19,120
interfere with many different pathway ููŠ ุงู„ู€

52
00:04:19,120 --> 00:04:24,440
cellular function ูˆุจุงู„ุชุงู„ูŠ ุจุชุคุฏูŠ ุฅู„ู‰ autoimmune

53
00:04:24,440 --> 00:04:29,740
disease ุงู„ุนูˆุงู…ู„ ุงู„ุชูŠ ุชุคุซุฑ ุนู„ู‰ ุงู„ู€ autoimmune disease

54
00:04:29,740 --> 00:04:32,120
ู‚ุงู„ูˆุง ุงู„ู€ over expression ุฃูˆ ุงู„ู€ under expression of

55
00:04:32,120 --> 00:04:36,020
ุฌูŠู† ูˆ ุจุงู„ุฐุงุช ุงู„ุฌูŠู†ุงุช ุงู„ุชูŠ are involved in

56
00:04:36,020 --> 00:04:37,760
apoptosis and cell survival

57
00:04:45,140 --> 00:04:46,120
ูˆุทุจูŠุนูŠ ุงู„ูˆุตูˆู„ ุฅู„ู‰ ุงู„ูˆุตูˆู„ ุฅู„ู‰ ุงู„ูˆุตูˆู„ ุฅู„ู‰ ุงู„ูˆุตูˆู„ ุฅู„ู‰

58
00:04:46,120 --> 00:04:46,860
ุงู„ูˆุตูˆู„ ุฅู„ู‰ ุงู„ูˆุตูˆู„ ุฅู„ู‰ ุงู„ูˆุตูˆู„ ุฅู„ู‰ ุงู„ูˆุตูˆู„ ุฅู„ู‰ ุงู„ูˆุตูˆู„

59
00:04:46,860 --> 00:04:50,020
ุฅู„ู‰ ุงู„ูˆุตูˆู„ ุฅู„ู‰ ุงู„ูˆุตูˆู„ ุฅู„ู‰ ุงู„ูˆุตูˆู„ ุฅู„ู‰ ุงู„ูˆุตูˆู„ ุฅู„ู‰

60
00:04:50,020 --> 00:04:54,620
ุงู„ูˆุตูˆู„ ุฅู„ู‰ ุงู„ูˆุตูˆู„ ุฅู„ู‰ ุงู„ูˆุตูˆู„ ุฅู„ู‰ ุงู„ูˆุตูˆู„ ุฅู„ู‰ ุงู„ูˆุตูˆู„

61
00:04:54,620 --> 00:04:58,460
ุฅู„ู‰ ุงู„ูˆุตูˆู„ ุฅู„ู‰ ุงู„ูˆุตูˆู„ ุฅู„ู‰ ุงู„ูˆุตูˆู„ ุฅู„ู‰ ุงู„ูˆุตูˆู„ ุฅู„ู‰

62
00:04:58,460 --> 00:05:01,100
ุงู„ูˆุตูˆู„ ุฅู„ู‰ ุงู„ูˆุตูˆู„ ุฅู„ู‰ ุงู„ูˆุตูˆู„ ุฅู„ู‰ ุงู„ูˆุตูˆู„ ุฅู„ู‰ ุงู„ูˆุตูˆู„

63
00:05:01,100 --> 00:05:07,420
ุฅู„ู‰ ุงู„ูˆุตูˆู„ ุฅู„ู‰ ุงู„ูˆุตูˆู„ ุฅู„ู‰ ุงู„ูˆุตูˆู„ ุฅู„ู‰ ุงู„ูˆุตูˆู„

64
00:05:09,640 --> 00:05:13,020
Deficiency in pro-apoptic molecules ุฒูŠ ุงู„ู€ Fas

65
00:05:13,020 --> 00:05:17,980
ูˆ ุงู„ู€ Fas Ligand ุฃูˆ ุงู„ู€ over expression of anti-apoptic

66
00:05:17,980 --> 00:05:23,640
molecules ุฒูŠ ุงู„ู€ BCL2 ูˆู‡ูˆ ุนุจุงุฑุฉ ุนู† ุฌูŠู† ุจูŠ code for ุงู„ู€

67
00:05:23,640 --> 00:05:29,390
protein ูŠู„ุนุจ ุฏูˆุฑ ูƒุจูŠุฑ ููŠ ุงู„ู€ apoptosis Can interfere

68
00:05:29,390 --> 00:05:36,350
the apoptosis ุทุจุนุง ุบูŠุงุจู‡ู… ุจูŠุคุฏูŠ ุฅู„ู‰ diminution of

69
00:05:36,350 --> 00:05:40,430
apoptosis ูˆุฅุฐุง ุตุงุฑ ููŠ diminution of apoptosis ุจูŠุตูŠุฑ

70
00:05:40,430 --> 00:05:45,630
ููŠู‡ ุฒูŠุงุฏุฉ ููŠ ุงู„ู€ auto reactive B and T cell ูˆู‡ุฐุง

71
00:05:45,630 --> 00:05:50,870
ุจูŠุคุฏูŠ ุฅู„ู‰ auto antibody production ูˆุทุจุนุง ุฃุดู‡ุฑ ู‡ุฐู‡

72
00:05:50,870 --> 00:05:56,870
ุงู„ู€ antibody ู‡ูˆ ุงู„ู€ antinuclear antibody ุงู„ู€ T cell

73
00:05:58,200 --> 00:06:06,500
ู…ู„ุงุญุธุฉ ุฃุฎุฑู‰ ุชุณู„ู„ auto reactivity ู„ุฌูˆู‡ุง ุฃูŠุถุง ุจุชุตูŠุฑ

74
00:06:06,500 --> 00:06:10,360
as a result of expression of pro inflammatory

75
00:06:10,360 --> 00:06:17,550
cytokine ุฒูŠ IL-10 ุฃูˆ excessive costimulation due to

76
00:06:17,550 --> 00:06:26,170
overexpression of B7C28 ูˆ a deficiency of

77
00:06:26,170 --> 00:06:32,490
inhibitor of costimulation reaction ู…ุงุดูŠ ูŠุจู‚ู‰ ู‡ุฐู‡

78
00:06:32,490 --> 00:06:41,720
ุจุฑุถู‡ ู„ู‡ุง ุนู„ุงู‚ุฉ ุจุงู„ู€ auto reactive T cell ุฃูŠุถุง ุงู„ู„ุนุจ

79
00:06:41,720 --> 00:06:46,700
ููŠ ุงู„ู€ strength of signal transduction ุฒูŠ ู…ุง ู‚ู„ู†ุง

80
00:06:46,700 --> 00:06:52,620
ุฃู†ู‡ ุฅุฐุง ูƒุงู† ููŠ ุฎู„ู„ ููŠ under expression ู„ู€ CD 22 ุฃูˆ

81
00:06:52,620 --> 00:07:04,760
over expression ู„ู€ CD 19 ุฃูŠุถุง

82
00:07:11,220 --> 00:07:16,920
Enhanced T Cell Helps

83
00:07:16,920 --> 00:07:21,040
Enhance

84
00:07:21,040 --> 00:07:25,140
Expression Of CD40 To 40-Ligand ุฃูŠุถุง Similarly

85
00:07:25,140 --> 00:07:33,400
Leads To Auto Antibody Production ู…ู„ุงุญุธุฉ ุฃุฎุฑู‰ ุฃูŠุถุง

86
00:07:33,400 --> 00:07:36,500
ุงู„ู„ูŠ ุนู„ุงู‚ุฉ ุจุงู„ู€ Auto Immune Disease ูู‡ูˆ Under

87
00:07:36,500 --> 00:07:39,900
Expression Of Protein ุฒูŠ ุงู„ู€ Serum Amyloid Protein

88
00:07:40,350 --> 00:07:43,850
ูˆู‡ุฐุง ุจู„ุนุจ ุฏูˆุฑ ูƒุจูŠุฑ ููŠ ุงู„ู€ clearance of apoptic

89
00:07:43,850 --> 00:07:46,650
particles ุฃูˆ decreased clearance of immune

90
00:07:46,650 --> 00:07:50,790
complexes ู†ุงุชุฌุฉ ุนู† deficiency of complement

91
00:07:50,790 --> 00:07:57,810
component either C1q, C2, C3 ุฃูˆ even C4 ู‡ู… ุจูŠุคุฏูˆุง

92
00:07:57,810 --> 00:08:00,230
ุงู„ุฏูˆุฑ ุฅู„ู‰ ุงู„ู€ auto antibody production

93
00:08:08,330 --> 00:08:13,790
ู…ุซุงู„ ุงู„ุญู‚ูŠู‚ูŠ ุนู„ู‰ ู‡ุฐุง ุงู„ูƒู„ุงู… ู‡ูˆ ุงู„ู€ Neuronal Model

94
00:08:13,790 --> 00:08:21,710
of Autoimmune Myocarditis which revealed that the

95
00:08:21,710 --> 00:08:26,210
disease susceptibility and cardiac damage ุจุชุนุชู…ุฏ

96
00:08:26,210 --> 00:08:31,030
ุนู„ู‰ Strain-specific cardiac myosin antigen

97
00:08:31,030 --> 00:08:36,110
Accessibility ูˆุงู„ูˆุถุน ุงู„ู„ูŠ ู‡ูˆ ุงู„ู€ myosin antigen ููŠ

98
00:08:36,110 --> 00:08:40,850
ุงู„ู€ cardiac tissue

99
00:08:40,850 --> 00:08:46,530
Environmental susceptibility ูŠุนู†ูŠ ููŠู‡ several

100
00:08:46,530 --> 00:08:49,090
environmental factors either infectious ุฃูˆ non

101
00:08:49,090 --> 00:08:53,120
-infectious which can trigger autoimmunity ูƒูŠูุŸ

102
00:08:53,120 --> 00:08:56,180
ุฌุงู„ู‡ by inducing release of sequestered antigen ุฃูˆ

103
00:08:56,180 --> 00:08:59,620
molecular mimicry ุฃูˆ polyclonal activation ูˆุญู†ุง

104
00:08:59,620 --> 00:09:03,180
ู†ุงุฎุฏ ุฃู…ุซู„ุฉ ุนู„ู‰ ู‡ุฐุง ุงู„ูƒู„ุงู… ูุนู„ู‰ ุณุจูŠู„ ุงู„ู…ุซุงู„ ุงู„ู€

105
00:09:03,180 --> 00:09:07,240
autoimmune myocarditis ูˆุฌุฏูˆุง ุงู„ู„ูŠ ู‡ูˆ ุนู„ุงู‚ุฉ ู…ุจุงุดุฑุฉ

106
00:09:07,240 --> 00:09:12,220
ุจุงู„ู€ myocardial infarction ุฃูˆ cardiac ischemic

107
00:09:12,220 --> 00:09:16,160
attack ุดูˆ ุจูŠุตูŠุฑ ููŠู‡ุงุŸ ุงู„ู€ cardiac ischemic attack

108
00:09:16,160 --> 00:09:21,580
ุจูŠุตูŠุฑ ููŠู‡ tissue damage ู„ุฃ cardiac damage ูˆุจุงู„ุชุงู„ูŠ

109
00:09:21,580 --> 00:09:25,940
ุจูŠุญุตู„ ููŠู‡ sequestered antigen ู„ู„ูƒุงุฑุฏูƒ ู…ุณู„ุฒ ุจูŠู‚ูˆู„ูˆุง ุฃู†

110
00:09:25,940 --> 00:09:29,600
ุณุจุจ ุงู„ู€ autoimmune myocarditis ู‡ูˆ ู†ุชุฌ ุนู† ุขุด ุงู„ู€

111
00:09:29,600 --> 00:09:32,780
consequences of exposure to sequestered antigen

112
00:09:32,780 --> 00:09:39,440
upon heart damage ุฃูŠุถุง ุงู„ู€ autoimmunity may also

113
00:09:39,440 --> 00:09:44,080
arise when an antibody ุฃูˆ T cell specific for

114
00:09:44,080 --> 00:09:48,740
microbial antigen cross react with self-antigen

115
00:09:48,740 --> 00:09:53,080
ุงู„ู…ุตุทู„ุญ ุงู„ูƒุชูŠุฑ ู…ุดู‡ูˆุฑ ุงู„ู„ูŠ ู‡ูˆ molecular mimicry ููŠ

116
00:09:53,080 --> 00:10:01,580
ุชุดุงุจู‡ ู…ุง ุจูŠู†ูŠุด foreign antigen ู…ุน self-antigen T

117
00:10:01,580 --> 00:10:08,760
cell dependent self-antigen ู„ุง ุชุณุชุทูŠุน ุฃู†ู‡ุง ุชุชู…ุดุท

118
00:10:10,550 --> 00:10:17,790
ุงู„ู€ B-cell ููŠ ุชูƒูˆูŠู† auto-antibody ู„ุฃู†ู‡

119
00:10:17,790 --> 00:10:22,650
there are no auto-reactive T-cell helper ูŠุนู†ูŠ ุงุญู†ุง

120
00:10:22,650 --> 00:10:25,950
ุจุจุณุงุทุฉ ุจูŠู‚ูˆู„ ุฃู† ุงู„ู€ B ู„ู†ูุณู‡ุง ุนูŠุทุด ูŠูˆู… ู…ุง ุชุตุนุฏ ููŠ

121
00:10:25,950 --> 00:10:31,990
ูุฑู† ุงู†ุชุฌูŠู† ูˆุชู…ุดูŠ ุจู‡ ู…ุงุจุชู‚ุฏุฑุด ุชุชู†ุดุท ู„ูŠุดุŸ ู„ุฃู†ู‡ ุงู„ู€ T

122
00:10:31,990 --> 00:10:39,020
-cell ู…ุทู„ูˆุจุฉ ุนุดุงู† ุชู†ุดุทูŠุนู†ูŠ ู…ุณุงุนุฏุฉ ู„ุง ุชุชู…ุดุท ุฅู„ุง

123
00:10:39,020 --> 00:10:42,500
ุจู…ุณุงุนุฏุฉ ุงู„ู€ T-Helper Cell ูˆุบุงู„ุจุง ุงู„ู€ T-Lymphocyte

124
00:10:42,500 --> 00:10:51,280
is either deleted or energized ูŠุนู†ูŠ ููŠ ุงู„ู€ primary

125
00:10:51,280 --> 00:10:55,870
lymphoid organs ู…ู† ุงู„ุจุฏุงูŠุฉ ุงู„ู€ T-Lymphocyte is well

126
00:10:55,870 --> 00:11:01,050
educated ูŠุนู†ูŠ ุจู…ุนู†ู‰ ุฃู†ู‡ ุจุชุชุนู„ู… ุตุญ ูˆุงู„ู…ุญุงุตุฑุฉ

127
00:11:01,050 --> 00:11:04,130
ุงู„ุชุนู„ูŠู… ูŠุงู…ุจุณูŠู„ ุงู†ุฏู„ูŠุดูŠู† ู„ู„-auto reactive

128
00:11:04,130 --> 00:11:12,910
telephosite ูŠุงู…ุจุณูŠู„ ุงู†ุฑุฌุฒุช ุงู„ู…ุดูƒู„ุฉ

129
00:11:12,910 --> 00:11:18,770
ู…ู…ูƒู† ุชุตูŠุฑ ู„ู…ุง ูŠูƒูˆู† ูุฑู† ุงู†ุชุฌู† ุจูŠุญุชูˆูŠ ุนู„ู‰ ุฅูŠุจูŠุชูˆุจ

130
00:11:18,770 --> 00:11:23,790
similar to ุฅูŠุจูŠุชูˆุจ of self-antigen ูˆุจุงู„ุชุงู„ูŠ ููŠ ู‡ุฐู‡

131
00:11:23,790 --> 00:11:27,340
ุงู„ุญุงู„ุฉ ุจูŠุตูŠุฑ ููŠู‡ ุชูƒูˆูŠู† ู„ู€ auto antibody response

132
00:11:27,340 --> 00:11:35,360
for the foreign antigen ุงู„ู„ูŠ ุฃูŠุถุง ู…ู…ูƒู† ูŠุชูุงุนู„ ู…ุน

133
00:11:35,360 --> 00:11:39,000
ุงู„ู€ self-antigen ู„ุฃู†ู‡ ุจูŠุตูŠุฑ ููŠู‡ cross reactivity ููŠ

134
00:11:39,000 --> 00:11:43,300
ู‡ุฐู‡ ุงู„ุญุงู„ุฉ ู‡ุฐุง ู…ุง ูŠุณู…ู‰ ุจุงู„ุฅูŠุด ุจุงู„ู€ molecular

135
00:11:43,300 --> 00:11:48,520
mimicry ูˆู†ุดูˆู ู‡ู†ุดูˆู ุฅู† ุดุงุก ุงู„ู„ู‡ ููŠ ุงู„ู€ figure 12.5

136
00:11:48,520 --> 00:11:55,050
ู‡ุฐุง ุงู„ูƒู„ุงู… molecular mimicry ู‡ูˆ ู…ุคูƒุฏ ุฃู†ู‡ ูŠุนู…ู„ ุฑูˆู„

137
00:11:55,050 --> 00:12:02,110
ููŠ ุงู„ุฑูˆู…ุงุชูŠูƒ ููŠูุฑ rheumatic fever

138
00:12:02,110 --> 00:12:07,230
ุงู„ูŠูˆู… ุชูƒูˆู† ุชู†ุชุฌ

139
00:12:07,230 --> 00:12:12,350
ู…ู† ู†ุชูŠุฌุฉ ุงุณุชุฑูŠุจุชูˆ ูƒูˆูƒุงู„ ุงู†ููƒุดู† ูŠุนู†ูŠ ู„ูˆ ููŠ ุจุนุถ ุงู„ู€

140
00:12:12,350 --> 00:12:17,150
cross reactivity ููŠ ุงู„ู€ streptococcal ูˆุงู„ู€ Cardic

141
00:12:17,150 --> 00:12:22,610
Myosin ุงู„ู„ูŠ ู‡ูˆ ุงู„ุจุฑูˆุชูŠู† ูˆุจุงู„ุชุงู„ูŠ ุจุชูƒูˆู† Auto

142
00:12:22,610 --> 00:12:28,610
Antibody which can cross-reactive with the Myosin

143
00:12:28,610 --> 00:12:34,450
in the heart Autoimmune

144
00:12:34,450 --> 00:12:38,190
Diabetes ูƒู…ุงู† ุชูŠู„ูŠู†ููˆุณุงูŠุช can recognize a peptide

145
00:12:38,190 --> 00:12:45,140
ูู‚ุท ุจูŠุจุชุงูŠุฏ ู…ู† ุงู„ู€ glutamic acid D-carboxylase ูˆู‡ุฐุง

146
00:12:45,140 --> 00:12:51,760
ุนุจุงุฑุฉ ุนู† ุงู†ุชุฌู† ู…ูˆุฌูˆุฏุฉ ููŠ ุงู„ู€ beta islet cell ู„ู‡

147
00:12:51,760 --> 00:12:56,700
ู‡ุฐุง ูƒุงู† cross reaction cross react with peptide

148
00:12:56,700 --> 00:13:01,740
derived from kokusaki virus ูŠุนู†ูŠ ููŠ ุชุดุงุจู‡ ู…ุง ุจูŠู†

149
00:13:01,740 --> 00:13:06,420
ุงู„ู„ูŠ ู‡ูˆ ุงู„ู€ kokusaki virus ูˆู…ุง ุจูŠู† a glutamic acid

150
00:13:06,420 --> 00:13:12,110
ุงู„ู„ูŠ ู‡ูˆ ุงู„ู€ b cell ุจู€ islet cell ุงู„ู„ูŠ ู‡ูˆ ู…ู† ุฎู„ุงู„

151
00:13:12,110 --> 00:13:17,530
Glutamic Acid Carboxylase Antigen ุฃูŠุถู‹ุง ุจูŠุตูŠุฑ ููŠู‡

152
00:13:17,530 --> 00:13:23,750
molecular mimicry ูˆุทุจุนู‹ุง ุงู„ู€ autoimmune disease can

153
00:13:23,750 --> 00:13:27,270
be developed

154
00:13:27,270 --> 00:13:35,270
ุจุนุฏ ู…ุง ูŠุตูŠุฑ ููŠู‡ microbial infection ูˆู‡ูˆ ู…ุซู„ู‹ุง ุฒูŠ

155
00:13:35,270 --> 00:13:38,760
ู…ุง ุฃู†ุชู… ุดุงูŠููŠู† ู‡ูŠ ุนุจุงุฑุฉ ุนู† auto-reactive B

156
00:13:38,760 --> 00:13:47,120
lymphocytes ู…ุงุณูƒุฉ ููŠ self-antigen ูˆุงู„ู€ self

157
00:13:47,120 --> 00:13:52,860
-antigen ุฏู‡ ู‡ูˆ ููŠ ู…ูŠูƒุฑูˆุจูŠุง ุงู„ู€ antigen ุจูŠุดุชุฑูƒ ู…ุนุงู‡

158
00:13:52,860 --> 00:13:58,440
ููŠ ุฅูŠุจูŠุชูˆุจ ุจูŠุดุชุฑูƒ ู…ุนุงู‡ ููŠ ุฅูŠุจูŠุชูˆุจ ุทุจุนู‹ุง ุงู„ู€ B

159
00:13:58,440 --> 00:14:06,380
lymphocytes ุชุชู…ุดุท for the foreign part ูˆุชุตุจุญ ู†ุดุทุฉ

160
00:14:06,380 --> 00:14:11,180
ูˆุนู†ุฏู…ุง ุชุตุจุญ ู†ุดุทุฉ ุชุตุจุญ ู†ุดุทุฉ ู„ู†ุง ุชูŠู„ูŠู†ููˆุณุงูŠุฏุณ ู„ู†ุงุณ

161
00:14:11,180 --> 00:14:19,400
ูƒู…ูŠู† ุงู„ูุฑู† ุงุจุชุฏูˆุง which can cause react with the

162
00:14:19,400 --> 00:14:24,900
self ุงุจุชุฏูˆุง ุชุทู„ุน auto antibody which can react ู…ุน

163
00:14:24,900 --> 00:14:29,900
ุงู„ู€ self ูˆู…ุน ุงู„ูุฑู† ู…ุน ุงู„ู€ self ูˆู…ุน ุงู„ูุฑู†

164
00:14:31,960 --> 00:14:36,540
ุทุจุนู‹ุง ู‡ุฐุง ู‡ูˆ ุงู„ูˆุถุน ุงู„ู„ูŠ ู‚ู„ู†ุง ุฃู†ู‡ ููŠ common ุฅูŠุจูŠุชูˆุจ

165
00:14:36,540 --> 00:14:43,440
ููŠ ุงู„ู€ foreign antigen ู…ุน ุงู„ู€ ash ู…ุน ุงู„ู€ self antigen

166
00:14:43,440 --> 00:14:47,400
ูุจุชุชู†ุดุท ุทุจุนู‹ุง ุชูŠู„ูŠู†ููˆุณุงูŠุช ู„ู„ู€ foreign ุฅูŠุจูŠุชูˆุจ ูุชู†ุดุท

167
00:14:47,400 --> 00:14:51,580
ุงู„ู€ naive ุชูŠู„ูŠู†ููˆุณุงูŠุช ุจูŠู„ูŠู…ููˆุณุงูŠุช ูˆุจูŠู„ูŠู…ููˆุณุงูŠุช ุชุทู„ุน

168
00:14:51,580 --> 00:14:57,240
antibody for both self and ash and foreign antigen

169
00:14:58,250 --> 00:15:00,590
ุงู„ุญุงุฌุฉ ุงู„ุชุงู„ุชุฉ ุงู„ู„ูŠ ุงุญู†ุง ุฅู† ุดุงุก ุงู„ู„ู‡ ู‡ู†ุญูƒูŠ ุนู„ูŠู‡ุง

170
00:15:00,590 --> 00:15:04,910
ุฒูŠ ู…ุง ุฃู†ุชู… ุดุงูŠููŠู† ูŠูˆู… ู…ุง ูŠุตูŠุฑ ููŠู‡ polyclonal

171
00:15:04,910 --> 00:15:09,770
polyclonal ูŠุนู†ูŠ ุฃูƒุซุฑ ู…ู† clone ุฃูˆ ุจูŠ ุณู„ ุงูƒุชู„ุงุดูŠูˆู†

172
00:15:09,770 --> 00:15:15,010
ุดูˆ ุงู„ู„ูŠ ุจูŠุตูŠุฑุŸ ูŠุนู†ูŠ ุจุชูƒูˆู† ุดูŠุก ุจูŠู†ู‡ู… auto reactive

173
00:15:15,010 --> 00:15:22,230
clone ูุฏู‡ ู‡ูŠ ุงู„ู€ auto reactive cell ููŠ ูŠูˆู… ู…ุง ูŠุฎุด big

174
00:15:22,230 --> 00:15:26,510
antigen ุฒูŠ ุงู„ู€ limopolysaccharides ู…ุงุดูŠุŸ which has

175
00:15:26,510 --> 00:15:32,680
ability to act as a super antigen ูุจุงู„ุชุงู„ูŠ ุจุฑูˆุญู‡ ู‡ูˆ

176
00:15:32,680 --> 00:15:40,540
ู…ุฑุชุจุท ู…ุงุดูŠ ูˆุทุจุนู‹ุง

177
00:15:40,540 --> 00:15:48,820
ุจุงู„ู€ receptor ุนู„ู‰ ุณุทุญ ุงู„ู€ ash ุจูŠุฑูŠู†ููˆุณุงูŠุช ุซู… ุจูŠ ูƒุงู†

178
00:15:48,820 --> 00:15:53,780
ุจูŠ associate with ุทูˆู„ ุงู„ู€ coreceptor ูˆุทูˆู„ ุงู„ู€ coreceptor

179
00:15:53,780 --> 00:15:58,750
ุจูŠุนู…ู„ signal transaction ูˆุจู†ุดุท ุงู„ู€ ash ุงู„ุนูŠุจ ุฃูˆ

180
00:15:58,750 --> 00:16:02,490
ุจูˆุฑูŠุณุง ูƒุฑู‡ุช ุจุชุจุช ุจุฑุณูŠุจุชูˆุฑ ู…ุฑุชุจุท ุจุงู„ุทู„ุนูŠ ูƒุฑุณูŠุจุชูˆุฑ

181
00:16:02,490 --> 00:16:05,210
which has the ability to induce signal

182
00:16:05,210 --> 00:16:11,250
transduction ูˆู…ุญุตู„ุชู‡ุง

183
00:16:11,250 --> 00:16:15,830
activation of cell ุทุจุนู‹ุง ูŠูˆู… ูŠุตูŠุฑ ููŠู‡ ุฃูƒุซุฑ ู…ู† ูƒู„ูˆู†

184
00:16:15,830 --> 00:16:19,210
activated ูˆู…ู† ุถู…ู†ู‡ู… auto reactive clone it will

185
00:16:19,210 --> 00:16:27,140
induce autoimmune disease ู‡ูŠ ุงู„ู€ Polyclonal

186
00:16:27,140 --> 00:16:31,120
Activation ุงู„ู€ Polyclonal Activator ูŠู…ูƒู† ุฃู† ูŠุฎู„ู‚

187
00:16:31,120 --> 00:16:33,020
ุงู„ู…ุงู„ ุจุดูƒู„ ู…ุญุฏุฏ ูŠุฎู„ู‚ ุงู„ู…ุงู„ ุจุดูƒู„ ู…ุญุฏุฏ ูŠุฎู„ู‚ ุงู„ู…ุงู„

188
00:16:33,020 --> 00:16:35,660
ุจุดูƒู„ ู…ุญุฏุฏ ูŠุฎู„ู‚ ุงู„ู…ุงู„ ุจุดูƒู„ ู…ุญุฏุฏ ูŠุฎู„ู‚ ุงู„ู…ุงู„ ุจุดูƒู„

189
00:16:35,660 --> 00:16:36,520
ู…ุญุฏุฏ ูŠุฎู„ู‚ ุงู„ู…ุงู„ ุจุดูƒู„ ู…ุญุฏุฏ ูŠุฎู„ู‚ ุงู„ู…ุงู„ ุจุดูƒู„ ู…ุญุฏุฏ

190
00:16:36,520 --> 00:16:36,820
ูŠุฎู„ู‚ ุงู„ู…ุงู„ ุจุดูƒู„ ู…ุญุฏุฏ ูŠุฎู„ู‚ ุงู„ู…ุงู„ ุจุดูƒู„ ู…ุญุฏุฏ ูŠุฎู„ู‚

191
00:16:36,820 --> 00:16:37,600
ุงู„ู…ุงู„ ุจุดูƒู„ ู…ุญุฏุฏ ูŠุฎู„ู‚ ุงู„ู…ุงู„ ุจุดูƒู„ ู…ุญุฏุฏ ูŠุฎู„ู‚ ุงู„ู…ุงู„

192
00:16:37,600 --> 00:16:38,440
ุจุดูƒู„ ู…ุญุฏุฏ ูŠุฎู„ู‚ ุงู„ู…ุงู„ ุจุดูƒู„ ู…ุญุฏุฏ ูŠุฎู„ู‚ ุงู„ู…ุงู„ ุจุดูƒู„

193
00:16:38,440 --> 00:16:39,820
ู…ุญุฏุฏ ูŠุฎู„ู‚ ุงู„ู…ุงู„ ุจุดูƒู„ ู…ุญุฏุฏ ูŠุฎู„ู‚ ุงู„ู…ุงู„ ุจุดูƒู„ ู…ุญุฏุฏ

194
00:16:39,820 --> 00:16:42,420
ูŠุฎู„ู‚ ุงู„ู…ุงู„ ุจุดูƒู„ ู…ุญุฏุฏ ู‡ูŠุญุตู„ ููŠู‡ autoimmune disease

195
00:16:42,420 --> 00:16:45,700
ู…ุซู„ ู…ุง ู‚ู„ู†ุง ู…ู† ู‚ุจู„ ูƒูˆู‡ุช ุจูŠู‡ูŠู ู…ุงู†ูŠ ุจูƒุชูŠุฑูŠุงู„ ุฃูˆ

196
00:16:45,700 --> 00:16:49,620
viral antigen can behave as a super antigen

197
00:16:49,620 --> 00:16:52,560
ูˆุจุงู„ุชุงู„ูŠ it will activate different clone of T

198
00:16:52,560 --> 00:16:59,760
cell ุจุบุถ ุงู„ู†ุธุฑ ุนู† ุงู„ู€ specificity ููŠ ู‡ุฐู‡ ุงู„ุญุงู„ุฉ

199
00:16:59,760 --> 00:17:05,240
ุทุจุนู‹ุง ุชุทุจู‚ ู…ุน ุงู„ู€ VB gene domain ุงู„ู„ูŠ ุจูŠูƒูˆู† ู…ูˆุฌูˆุฏ

200
00:17:05,240 --> 00:17:07,380
outside the peptide binding domain

201
00:17:10,810 --> 00:17:16,630
ู…ุงู†ูŠ ูƒู†ุฒูŠุฑุฏ ู…ูˆู„ูŠูƒูŠ ู„ุงุฑุณุชูƒุชุดุงุฑ ุงู„ู„ูŠ ู‡ูŠ ุงู„ู€ BAMs ุงู„ู„ูŠ 

202
00:17:16,630 --> 00:17:19,330
ู…ูˆุฌูˆุฏุฉ ุนู„ู‰ ู…ุงูŠูƒุฑูˆ ุฃูˆุฑุฌุงู†ูŠุฒู… ุงู„ู„ูŠ ู‡ูŠ ุงู„ู€ BAMs

203
00:17:19,330 --> 00:17:21,990
ุณู…ูŠู†ุงู‡ุง pathogen associated molecular pattern

204
00:17:21,990 --> 00:17:26,750
ุจุชู„ุนุจ ุฏูˆุฑ ูƒุจูŠุฑ ูƒุงูŠุงุด ูƒู€ polyclonal activator ู„ู€ ุจูŠ

205
00:17:26,750 --> 00:17:31,110
ุณูŠู„ ุทุจุนู‹ุง ุจุชุนุชุจุฑ ุงู„ุชู„ุณู†ุชุฑ ููŠ ู‡ุฐู‡ ุงู„ุญุงู„ุฉ pattern

206
00:17:31,110 --> 00:17:36,270
recognition molecule ุงู„ู„ูŠ ู…ุฑุชุจุท ุจุงู„ู€ BAMB ูˆุจู†ุดุทุฑู†ุง

207
00:17:36,270 --> 00:17:40,130
ุงู„ู€ B-lymphocyte as well as other ุทุจุนู‹ุง cell,

208
00:17:40,670 --> 00:17:45,610
lipopolysaccharides can polychronally activate ุงู„ู€

209
00:17:45,610 --> 00:17:49,950
mouse B-cell ุจู…ุง ููŠู‡ุง ุงู„ู€ auto-reactive B-cell ู…ู†

210
00:17:49,950 --> 00:17:53,730
ุฎู„ุงู„ interaction with receptor on the cell surface

211
00:17:53,730 --> 00:18:01,270
ุงู„ู„ูŠ ู…ุฑุชุจุท ุจุชูˆู„ุนูƒ receptor 4 ุดูู†ุงู‡ุง ููŠ ุงู„ุงุดูŠุงุก ุทุจุนู‹ุง

212
00:18:01,270 --> 00:18:08,090
ุงู„ูŠูˆู… ุจูŠู‚ูˆู„ูˆุง ุฃู†ู‡ ุฃุญุฏ ุงู„ู†ุธุฑูŠุงุช ุงู„ู…ุทุฑูˆุญุฉ ุฃู†ู‡ ุงู„ู€

213
00:18:08,090 --> 00:18:10,770
innate signaling through toll-like receptors

214
00:18:10,770 --> 00:18:15,190
pathway may be a mechanism for activating

215
00:18:15,190 --> 00:18:20,070
energetic B cell ุญุชู‰ ุงู„ู€ energetic B cell can be

216
00:18:20,070 --> 00:18:27,790
activated trigger

217
00:18:27,790 --> 00:18:32,900
of autoimmunity ุฅูŠุด ู‡ูŠ ุงู„ุนูˆุงู…ู„ ุงู„ู„ูŠ ุงุญู†ุง ู‚ู„ู†ุง ุจุฃู†ู‡ุง

218
00:18:32,900 --> 00:18:37,340
environmental factor ุฏู‡ ุงู„ู€ trigger ุงู„ู„ูŠ ู‡ูˆ ุฅู† ุฃู†ุง

219
00:18:37,340 --> 00:18:42,860
ุฃุฎูˆุฑ chemical substance ู‡ูˆุฑู…ูˆู† ููŠ ุงู„ู€ SLE ุจูŠู‚ูˆู„ูˆุง ู‡ูˆ

220
00:18:42,860 --> 00:18:46,720
is ten times more common in women than in men

221
00:18:46,720 --> 00:18:52,700
ูˆุงู„ุณุจุจ ููŠ ุฐู„ูƒ ุงู„ุงุณุชุฑูˆุฌูŠู† Searching drug can

222
00:18:52,700 --> 00:18:56,780
chemically alter T cell carrier epitope of a self

223
00:18:56,780 --> 00:19:01,750
-antigen to render it immunogenic ุชุญูˆู„ ุงู„ู€ self

224
00:19:01,750 --> 00:19:08,750
-antigen ุฅู„ู‰ immunogenic antigen ู†ุตู ุณุจุฑูŠุณูˆู T

225
00:19:08,750 --> 00:19:14,990
cell TS can contribute to autoimmune disease ู‡ูŠ

226
00:19:14,990 --> 00:19:22,750
ุทุจุนู‹ุง ุช ุงุณู… ุดุงูŠููŠู†ู‡ุง ู‡ูŠ T suppressor cell which can

227
00:19:22,750 --> 00:19:27,330
suppress the activity of both CD4 and CD8 ูุทุจุนู‹ุง

228
00:19:27,330 --> 00:19:31,840
ุบูŠุงุจู‡ุง ู‡ูŠุคุฏูŠ ุฅู„ู‰ cell related immunity ุจูƒุซุฑุฉ which

229
00:19:31,840 --> 00:19:35,080
can lead to autoimmune disease ูŠุนู†ูŠ ูŠุดุชุบู„ ูƒุซูŠุฑ

230
00:19:35,080 --> 00:19:37,980
ูˆุจุงู„ุชุงู„ูŠ ุจุชุบู„ุท ูƒุซูŠุฑ ูˆุจุงู„ุชุงู„ูŠ ุจูŠุตูŠุฑ ููŠู‡ autoimmune

231
00:19:37,980 --> 00:19:41,300
disease ุงู„ู†ุงุณ ุงู„ู„ูŠ ุนู†ุฏู‡ู… diabetes ูˆุนู†ุฏู‡ู…

232
00:19:41,300 --> 00:19:46,080
inflammatory bowel syndrome ุฃูŠุถู‹ุง ุนู†ุฏู‡ู… ู‚ู„ุฉ ููŠ ุงู„ู€

233
00:19:46,080 --> 00:19:51,680
TS cell  ู†ุงุฎุฏ

234
00:19:51,680 --> 00:19:56,660
ุฃู…ุซู„ุฉ ุนู„ู‰ ุงู„ู€ autoimmune disease ูˆุทุจุนู‹ุง ู†ุจุฏุฃ ุจุงู„ู€

235
00:19:57,940 --> 00:20:04,020
ุฃู…ุซู„ุฉ ุฃูˆ ุงู„ุฃู…ุฑุงุถ ุงู„ู„ูŠ ุจูŠูƒูˆู† ุงู„ู€ antibody ู„ู‡ ุฏูˆุฑ

236
00:20:04,020 --> 00:20:13,000
ุฃุณุงุณูŠ ููŠ ุงู„ู€ organ damage ูˆุฃุดู‡ุฑู‡ุง ู‡ุฐู‡ ุฃูˆ ุจุฏุงูŠุฉ

237
00:20:13,000 --> 00:20:16,720
ู†ุจุฏุฃ ุจุงู„ู€ autoimmune hemolytic anemia ูƒู„ู†ุง ุจู†ุนุฑู

238
00:20:16,720 --> 00:20:20,860
ุฃู†ู‡ ุจูŠุชูƒูˆู† auto antibody against RBCs antigen

239
00:20:20,860 --> 00:20:25,700
ูˆุจุงู„ุชุงู„ูŠ ุจูŠุตูŠุฑ ููŠู‡ ู‚ู„ุฉ ููŠ ุนุฏุฏ ุงู„ู€ RBCs ู„ุฃู†ู‡ุง ุจุชุชูƒุณุฑ

240
00:20:26,980 --> 00:20:31,480
ูˆุงู„ุชูƒุณูŠุฑ ู‡ูŠุชู… ู…ู† ุฎู„ุงู„ two mechanism ุงู„ุฃูˆู„ุงู†ูŠ ู…ู†

241
00:20:31,480 --> 00:20:36,100
ุฎู„ุงู„ activation of complement cascade ูƒุงู…ู„ุฉ ูŠุนู†ูŠ

242
00:20:36,100 --> 00:20:42,000
ู„ู„ุขุฎุฑ ูˆู…ุญุตู„ุชู‡ eventual license of the cell ูˆู‡ุฐุง

243
00:20:42,000 --> 00:20:47,840
ุบุงู„ุจุงู‹ ุจู†ุดูˆู hemoglobin or urea ุจูˆุถูˆุญ ุนู†ุฏ ุงู„ู…ุฑูŠุถ

244
00:20:47,840 --> 00:20:53,260
ู…ูŠูƒุงู†ูŠุฒู… ุงู„ุซุงู†ูŠ ู‡ูˆ ุฃู†ู‡ ูŠุตูŠุฑ ููŠู‡ optionization ู…ู†

245
00:20:53,260 --> 00:21:00,290
ุฎู„ุงู„ ุฃูˆ ุงู„ู€ C3P ุนู„ู‰ ุณุทุญ ุงู„ู€ RBCs ูˆู‡ุคู„ุงุก ู„ุฏูŠู‡ู…

246
00:21:00,290 --> 00:21:03,570
ุฑูŠุณุจุชูˆุฑ ุนู„ู‰ ุณุทุญ ุงู„ู…ุงูƒุฑูˆููŠุฌูŠ ุงู„ู…ูˆุฌูˆุฏุฉ ููŠ ุงู„ู€

247
00:21:03,570 --> 00:21:06,670
reticulum nucleus system ูŠุนู†ูŠ ููŠ ุงู„ู€ Spleen

248
00:21:06,670 --> 00:21:10,930
ูˆุจุงู„ุชุงู„ูŠ ุฃูˆู„ ู…ุง ุชุตู„ ุณูŠุญุตู„ ููŠู‡ Antibody-coated RBCs

249
00:21:10,930 --> 00:21:17,550
recognition ุฃูˆ complement-coated RBCs recognition

250
00:21:17,550 --> 00:21:21,850
ูˆุงู„ู…ุญุตู„ุฉ ูุงู„ุจูˆุตูŠุชูˆุณูŠุฒ ูˆdestruction of the cell 

251
00:21:24,650 --> 00:21:28,630
ูƒุงู† ุงู„ุงู†ุชูŠุจุงุฏูŠ ุงู„ู…ุณุฆูˆู„ ุนู† ุงู„ู€ autoimmunohepatic

252
00:21:28,630 --> 00:21:33,610
anemia ูŠุชู… ู…ู‚ุงุทุนู‡ ุฅู„ู‰ ุงุชุฌุงุฑุงุช ุชุฌุงุฑูŠุฉ

253
00:21:33,610 --> 00:21:35,170
ุชุฌุงุฑูŠู‘ุฉ ุชุฌุงุฑูŠู‘ุฉ ุชุฌุงุฑูŠู‘ุฉ ุชุฌุงุฑูŠู‘ุฉ ุชุฌุงุฑูŠู‘ุฉ ุชุฌุงุฑูŠู‘ุฉ

254
00:21:35,170 --> 00:21:37,310
ุชุฌุงุฑูŠู‘ุฉ ุชุฌุงุฑูŠู‘ุฉ ุชุฌุงุฑูŠู‘ุฉ ุชุฌุงุฑูŠู‘ุฉ ุชุฌุงุฑูŠู‘ุฉ ุชุฌุงุฑูŠู‘ุฉ

255
00:21:37,310 --> 00:21:38,850
ุชุฌุงุฑูŠู‘ุฉ ุชุฌุงุฑูŠู‘ุฉ ุชุฌุงุฑูŠู‘ุฉ ุชุฌุงุฑูŠู‘ุฉ ุชุฌุงุฑูŠู‘ุฉ ุชุฌุงุฑูŠู‘ุฉ

256
00:21:38,850 --> 00:21:39,590
ุชุฌุงุฑูŠู‘ุฉ ุชุฌุงุฑูŠู‘ุฉ ุชุฌุงุฑูŠู‘ุฉ ุชุฌุงุฑูŠู‘ุฉ ุชุฌุงุฑูŠู‘ุฉ ุชุฌุงุฑูŠู‘ุฉ

257
00:21:39,590 --> 00:21:40,050
ุชุฌุงุฑูŠู‘ุฉ ุชุฌุงุฑูŠู‘ุฉ ุชุฌุงุฑูŠู‘ุฉ ุชุฌุงุฑูŠู‘ุฉ ุชุฌุงุฑูŠู‘ุฉ ุชุฌุงุฑูŠู‘ุฉ

258
00:21:40,050 --> 00:21:48,030
ุชุฌุงุฑูŠู‘ุฉ ุชุฌุงุฑูŠู‘ุฉ ุชุฌุงุฑูŠู‘ุฉ ุชุฌุงุฑูŠู‘ุฉ ุชุฌุงุฑูŠู‘ุฉ ุชุฌุงุฑ

259
00:21:48,670 --> 00:21:52,850
ุบุงู„ุจุง ุจูŠุฑุชุจุทูˆุง ู…ุน ุงู„ู€ RBCs ูู‚ุท ู„ู…ุง ุชูƒูˆู† ุฏุฑุฌุฉ

260
00:21:52,850 --> 00:21:57,170
ุงู„ุญุฑุงุฑุฉ ุฃู‚ู„ ู…ู† ุณุจุนุฉ ูˆุซู„ุงุซูŠู† ุฏุฑุฌุฉ ู…ุฆูˆูŠุฉ ูˆ ุจูŠููƒูˆุง

261
00:21:57,170 --> 00:22:01,770
ูŠุนู†ูŠ ุจูŠุณูŠุจูˆุง ุงู„ู€ RBCs ูŠูˆู… ุชุฑุชูุน ุฏุฑุฌุฉ ุงู„ุญุฑุงุฑุฉ they

262
00:22:01,770 --> 00:22:05,390
are IgM type and they are highly efficient in

263
00:22:05,390 --> 00:22:09,430
activating complement ูˆุจุงู„ุชุงู„ูŠ ุงู„ู…ุญุตู„ุฉ licenses

264
00:22:09,430 --> 00:22:10,470
of RBCs

265
00:22:12,920 --> 00:22:16,220
ุงู„ูˆุงุฌู‡ุฉ ุฏู„ูˆู‚ุช ุฃูŠุถุง ุฌู‡ูˆุชูƒ ุฃู†ูŠู…ูŠุง ูŠู…ูƒู† ุฃู† ุชูƒูˆู† ุงู†ุฏูˆุฒุช 

266
00:22:16,220 --> 00:22:21,460
ุจุจุนุถ ุงู„ุฃุฏูˆูŠุฉ ู…ุซู„ ุงู„ุจู†ุณู„ูŠู† ูˆุงู„ุฃู„ูุง ู…ุซุงู„ ุฏูˆุฑุจุง

267
00:22:21,460 --> 00:22:28,780
ูˆุจุนุถ ุงู„ู…ุฑุงุช ุจู†ู„ุงู‚ูŠ cold antibody ุชูƒูˆู†ุช ุจุนุฏ ุงู†ููƒุงุด

268
00:22:28,780 --> 00:22:36,340
ู…ุน  ุงู„ุชู‡ุงุจ ุฑุฆูˆูŠ ุฃูˆ ุจุนุถ ุงู„ููŠุฑูˆุณุงุช ุงู„ู…ุฑุถูŠุฉ

269
00:22:36,340 --> 00:22:41,950
ุงู„ุชุงู†ูŠ ู‡ูˆ myasthenia gravis ุทุจุนุง ููŠ ู‡ุฐู‡ ุงู„ุญุงู„ุฉ ุงู„

270
00:22:41,950 --> 00:22:48,330
target self-antigen ู‡ูˆ ุงู„ู€ Acetylcholine receptor ูˆ

271
00:22:48,330 --> 00:22:52,950
ุทุจุนุง ููŠ ู‡ุฐู‡ ุงู„ุญุงู„ุฉ ู…ูˆุฌูˆุฏ ุนู„ู‰ ุงู„ู€ neuromuscular

272
00:22:52,950 --> 00:22:56,970
junction ู‡ูˆ ุงู„ู€ Acetylcholine ู…ุญุชูˆู‰ ุงู„

273
00:22:56,970 --> 00:23:00,270
neuromuscular junction ูˆ ุจุงู„ุชุงู„ูŠ ู…ูˆุฌูˆุฏ ุนู„ู‰ ุงู„

274
00:23:00,270 --> 00:23:04,190
muscle cell ูˆ ุจุงู„ุชุงู„ูŠ ุงู„ู€ auto-antibody ุงู„ู„ูŠ ุจูŠุชูƒูˆู†

275
00:23:04,190 --> 00:23:08,080
ุจูŠู„ุนุจ ุฏูˆุฑ ูƒุจูŠุฑ as antagonist ุจุนู…ู„ Blocking ู„ู„ู€

276
00:23:08,080 --> 00:23:11,440
Acetylcholine Receptor ูู„ู…ุง ุจูŠุฌูŠ ุงู„ู€ Acetylcholine

277
00:23:11,440 --> 00:23:16,810
ูŠุดุชุบู„ ุจูŠู„ุงู‚ูŠ ุงู„ู€ Receptor ู…ุดุบูˆู„ ูˆุจุงู„ุชุงู„ูŠ ู…ุง ุจูŠุตูŠุฑ

278
00:23:16,810 --> 00:23:23,570
ููŠู‡ neuromuscular junction ูŠุนู†ูŠ ู…ุง ุจูŠุตูŠุฑ ููŠู‡

279
00:23:23,570 --> 00:23:28,070
muscle function ูˆุจุงู„ุชุงู„ูŠ ุจูŠุตูŠุฑ ููŠู‡ weakness ูˆุทุจุนุง

280
00:23:28,070 --> 00:23:33,850
ู‡ุฐู‡ ู…ุญุตู„ุชู‡ุง ุทุจุนุง ู…ู† ู…ุธุงู‡ุฑู‡ุง ูˆ ุจูŠุตูŠุฑ difficulty in

281
00:23:33,850 --> 00:23:38,510
chewing, swallowing ูˆ breathing ูˆ ููŠ ุงู„ู†ู‡ุงูŠุฉ

282
00:23:38,510 --> 00:23:42,010
ุจูŠุตูŠุฑ ููŠู‡ respiratory failure and death

283
00:23:44,940 --> 00:23:52,100
ุงู„ุนู†ูˆุงู† ูŠุจุฏูˆ ุฃู†ู‡ ู…ุฑุชุจุท ุจุงู„ู€ Thymus ุงู„ู…ุฑูƒูˆู„ุงุช

284
00:23:52,100 --> 00:23:57,440
ุงู„ู…ุชุนุงู…ู„ุฉ ู…ุน ุงู„ู€ Acetylcholine Receptor ู…ูˆุฌูˆุฏุฉ ููŠ ุงู„ุนุฏูŠุฏ ู…ู†

285
00:23:57,440 --> 00:24:02,440
ุงู„ุฃุฌุณุงู… ููŠ ุงู„ู€ Thymus ู…ุซู„ ุงู„ู€ Thymocytes ูˆ ุงู„ู€

286
00:24:02,440 --> 00:24:07,300
Epithelial cells ูˆู‡ูŠ 

287
00:24:07,300 --> 00:24:12,560
ุทุจุนุง ู‡ูŠ ุตูˆุฑุฉ ูˆุงุถุญุฉ ุฌุฏุง ุงู„ุงู†ุชูŠุจุงุฏูŠ ู…ุงุดูŠ

288
00:24:14,400 --> 00:24:28,100
ุฅูŠุด ุนู…ู„ุช ููŠ ู‡ุฐู‡ ุงู„ุญุงู„ุฉุŸ ุนู…ู„ุช Blocking ู„ู„ู€ Receptor

289
00:24:28,100 --> 00:24:30,480
ู„ุฅูŠุด ู„ุฅูŠุด ู„ุฅูŠุด ู„ุฅูŠุด ู„ุฅูŠุด ู„ุฅูŠุด ู„ุฅูŠุด ู„ุฅูŠุด ู„ุฅูŠุด ู„ุฅูŠุด

290
00:24:30,480 --> 00:24:30,520
ู„ุฅูŠุด ู„ุฅูŠุด ู„ุฅูŠุด ู„ุฅูŠุด ู„ุฅูŠุด ู„ุฅูŠุด ู„ุฅูŠุด ู„ุฅูŠุด ู„ุฅูŠุด ู„ุฅูŠุด

291
00:24:30,520 --> 00:24:35,720
ู„ุฅูŠุด ู„ุฅูŠุด ู„ุฅูŠุด ู„ุฅูŠุด ู„ุฅูŠุด

292
00:24:35,720 --> 00:24:36,500
ู„ุฅูŠุด ู„ุฅูŠุด ู„ุฅูŠุด ู„ุฅูŠุด ู„ุฅูŠุด ู„ุฅูŠุด ู„ุฅูŠุด ู„ุฅูŠุด ู„ุฅูŠุด ู„ุฅูŠุด

293
00:24:36,500 --> 00:24:41,240
ู„ุฅูŠุด ู„ุฅูŠุด ู„ุฅูŠุด ู„ุฅูŠุด ู„ุฅูŠุด

294
00:24:41,240 --> 00:24:42,000
ู„ุฅ

295
00:24:44,510 --> 00:24:47,250
ููŠ ุงู„ู€ Graves Disease ุงู„ู€ Antibody is stimulating

296
00:24:47,250 --> 00:24:50,610
ู‡ู†ุง ุงู„ู€ Antibody is inhibiting Antibody ู‡ู†ุง

297
00:24:50,610 --> 00:24:54,930
Stimulating Antibody ุจู„ุนุจ ุฏูˆุฑ ูƒุจูŠุฑ ุงุฒ ู…ู…ุณูƒ ููŠ TSH

298
00:24:54,930 --> 00:25:00,650
Receptor ูˆ TSH ู…ู† ุงุญู†ุง ุจู†ุนุฑู ุงู†ู‡ ุงูŠุด ูˆ ู…ู‚ูˆู… ุจุฏูˆุฑู‡

299
00:25:00,650 --> 00:25:04,410
ุทุจุนุง ุจู†ุนุฑู ุงู†ู‡ ุจุนู…ู„ activating ู„ู„ู€ thyroid follicle

300
00:25:04,410 --> 00:25:09,010
ูˆ ุจุชุทู„ุน ุงู†ู‡ุง thyroid hormone ูุจุงู„ุชุงู„ูŠ ู…ุญุตู„ุฉ ุงู„ู„ูŠ

301
00:25:09,010 --> 00:25:15,330
ู‡ูˆ ุงู„ู€ Graves Disease ู‡ูˆ Hyperthyroidism ู…ุงุดูŠ ู†ุฏู‰

302
00:25:15,330 --> 00:25:21,310
ุชุญู‚ู‚ ู†ุดูˆู ุงูŠู‡ disease ูˆู‚ูˆู„ู†ุง ู‡ูŠ hyperthyroidism

303
00:25:21,310 --> 00:25:27,870
antibody directed against a hormone receptor ุงู„ู„ูŠ

304
00:25:27,870 --> 00:25:34,290
ุจูŠุนู…ู„ ุนู„ู‰ ุชู†ุดูŠุท ุงู„ู€ receptor ูˆุจุงู„ุชุงู„ูŠ ุงู„ู…ุญุตู„ุฉ ุทุจุนุง

305
00:25:34,290 --> 00:25:37,830
ุงู„ู€ hormone ู‡ูˆ thyroid stimulating hormone ูˆ ุงู„

306
00:25:37,830 --> 00:25:44,630
interaction ุจูŠุคุฏูŠ ุงู„ู‰ ุงู„ู„ูŠ ู‡ูˆ ู†ุดุงุท ุงู„ุบุฏุฉ ู„ุฃู†ู‡

307
00:25:44,630 --> 00:25:50,490
ูŠุชุจุนู‡ ูƒู€ agonist ูˆู…ุญุตู„ุชู‡ ุทุจุนุง hyperthyroidism

308
00:25:50,490 --> 00:25:59,250
ุงู„ุฃุณุฆู„ุฉ E ุจุฑุถู‡ autoimmune disease ู…ุดู‡ูˆุฑ ุจุงุณู… Red

309
00:25:59,250 --> 00:26:05,930
wolf ุงู„ู„ูŠ ู‡ูˆ ุงู„ุฐุฆุจ ุงู„ุฃุญู…ุฑ ุทุจุนุง ู†ุชูŠุฌุฉ ุงู„ู€ reddish

310
00:26:06,300 --> 00:26:11,360
facial rash ุงู„ู„ูŠ ู…ูˆุฌูˆุฏุฉ ุนู„ู‰ ุงู„ู€ cheeks ูˆ ุฏูŠ ุบุงู„ุจุง

311
00:26:11,360 --> 00:26:18,380
ุจุชุนุชุจุฑ early symptoms ููŠ ู‡ุฐู‡ ุงู„ุญุงู„ุฉ ุงู„ู€ disease

312
00:26:18,380 --> 00:26:23,940
ุทุจุนุง attacks many organs of the body ูˆุจูŠุณุจุจ fever,

313
00:26:24,100 --> 00:26:26,900
joint pain, damage to the central nervous system,

314
00:26:27,220 --> 00:26:31,920
to the heart, to the kidney ูˆุจุงู„ุชุงู„ูŠ ูƒู„ ุนุถูˆ ุงู„ุฌุณู…

315
00:26:31,920 --> 00:26:36,570
ู…ู…ูƒู† ูŠุตูŠุจู‡ damage ูˆู…ุญุตู„ุชู‡ ุทุจุนุง ูˆูุงุฉ ููŠ ุงู„ู†ู‡ุงูŠุฉ

316
00:26:36,570 --> 00:26:42,350
ุงู„ู…ุดูƒู„ุฉ ููŠ ู‡ุฐุง ุงู„ู…ุฑุถ ุฃู†ู‡ there is not a systemic

317
00:26:42,350 --> 00:26:47,030
pathway ูŠุนู†ูŠ ู…ุง ููŠุด ุทุฑูŠู‚ ูŠุนู†ูŠ ูŠุนู†ูŠ ู…ุด ูƒู„ ู…ุฑุฉ ุงู„ู…ุฑุถ

318
00:26:47,030 --> 00:26:54,910
ุจูŠุณู„ูƒ ู†ูุณ ุงู„ุชุณู„ุณู„ ููŠ ุงู„ู„ูŠ ู‡ูˆ ุชุฎุฑูŠุจ ุฃุนุถุงุก ุงู„ุฌุณู…

319
00:26:54,910 --> 00:26:58,970
ุฃุณู‡ู„ patient produce antibodies against several

320
00:26:58,970 --> 00:27:02,490
nuclear components ู…ู†ู‡ุง ุงู„ู€ antinuclear antibody

321
00:27:03,020 --> 00:27:08,620
ู‡ุคู„ุงุก ุฃูŠุถุง ู…ุตุงุฏุฑ ุถุฏ ุงู„ู€ Denaturated Single

322
00:27:08,620 --> 00:27:17,620
-Stranded DNA ูˆุถุฏ ู†ูŠูƒู„ูŠูˆู‡ูŠุณุชูˆุฒ ุงู„ู€ Anti-Double

323
00:27:17,620 --> 00:27:24,440
-Stranded DNA ุทุจุนุง

324
00:27:24,440 --> 00:27:27,460
ุจู†ุดูˆูู‡ ุจูƒุซุฑุฉ ููŠ ุงู„ู†ุงุณ ุงู„ู„ูŠ ุนู†ุฏู‡ู… ุฎู„ุงู„ ูุฑูŠู†ุฉ ุงู„

325
00:27:27,460 --> 00:27:34,170
involvement ููŠ ุงู„ุฃุณุฆู„ุฉ E ุงู„ุฅูŠุฌูŠ ุฃู… ุงู„ุฃู†ุชูŠุจูˆุฏูŠุงุช

326
00:27:34,170 --> 00:27:37,550
ุชู†ุชุฌ ู…ู† ุฃุฌู„ ุงู„ู€ Single-Strand DNA ูŠู…ูƒู†ู‡ุง ุฃู† ุชุชุนุงู…ู„

327
00:27:37,550 --> 00:27:42,490
ู…ุน ุชุบูŠูŠุฑ ุฅูŠุฒูˆุชูŠุจูŠ ู„ุชู†ุชุฌ ุฅูŠุฌูŠ ุฌูŠ ุนุงู„ูŠ ุงููŠู†ูŠุชูŠ ุงู„ู€

328
00:27:42,490 --> 00:27:48,490
Double-Strand DNA ูŠุชุนุงู…ู„ .. ูŠุชุนุงู…ู„ .. ูŠุชุนุงู…ู„ ..

329
00:27:48,490 --> 00:27:49,910
ูŠุชุนุงู…ู„ .. ูŠุชุนุงู…ู„ .. ูŠุชุนุงู…ู„ .. ูŠุชุนุงู…ู„ .. ูŠุชุนุงู…ู„ ..

330
00:27:49,910 --> 00:27:51,630
ูŠุชุนุงู…ู„ .. ูŠุชุนุงู…ู„ .. ูŠุชุนุงู…ู„ .. ูŠุชุนุงู…ู„ .. ูŠุชุนุงู…ู„ ..

331
00:27:51,630 --> 00:27:54,770
ูŠุชุนุงู…ู„ .. ูŠุชุนุงู…ู„ .. ูŠุชุนุงู…ู„ .. ูŠุชุนุงู…ู„ .. ูŠุชุนุงู…ู„ ..

332
00:27:54,770 --> 00:27:56,470
ูŠุชุนุงู…ู„ .. ูŠุชุนุงู…ู„ ..

333
00:28:00,190 --> 00:28:05,350
Trapping of IgG Antibody or Anti-Double-Stranded

334
00:28:05,350 --> 00:28:11,990
DNA ุจูŠุคุฏูŠ ู„ุชูƒูˆูŠู† Immune Complexes ููŠ ุงู„ู€ glomerulus

335
00:28:11,990 --> 00:28:18,690
ูˆุทุจุนุง ู‡ุฐุง ุจูŠุคุฏูŠ ู„ุชู†ุดูŠุท ุงู„ู€ complement ูˆุจุนู…ู„

336
00:28:18,690 --> 00:28:24,910
recruitment ู„ู„ู€ granulocytes ูˆู…ุญุตู„ุฉ ุฑูŠู†ุงู„ ุฏุงู…ุฌ Anti

337
00:28:24,910 --> 00:28:27,970
-Double-Stranded DNA Antibody ุจูŠ cross-react

338
00:28:27,970 --> 00:28:33,660
ู„ู„ู€ glomerulus ูˆู‡ูŠ ุทุจุนุง ุฒูŠ ุงู„ู€ extent of inflammatory

339
00:28:33,660 --> 00:28:41,480
reaction ุจุชุนุชู…ุฏ ุนู„ู‰ ุฃูˆ ู‡ูŠ ู…ู† ูŠุญุฏุฏ severity of

340
00:28:41,480 --> 00:28:45,820
kidney pathology ุงู„ู…ุญุตู„ุฉ

341
00:28:45,820 --> 00:28:48,840
ุงู„ู„ูŠ ู‚ู„ู†ุงู‡ glomerulonephritis ูˆ ุงู„ู€ severity ุทุจุนุง

342
00:28:48,840 --> 00:28:53,580
ุจุชุคุฏูŠ ุฅู„ู‰ leakage of protein ู…ู† ุงู„ู€ blood ู…ู† ุงู„ู€

343
00:28:53,580 --> 00:29:00,740
kidney ูˆูƒู„ ู…ุง ุตุงุฑุช ุงู„ุญุงู„ุฉ chronic Inflammatory CD4

344
00:29:00,740 --> 00:29:06,200
ุงู„ู„ูŠ ุฏูŠ ุงู„ู€ protein ุงู„ู„ูŠ ู‡ุชู†ุดุทู„ู†ุง ุงู„ู€ macrophage ูˆ ุงู„

345
00:29:06,200 --> 00:29:10,600
can attract monocytes ุงู„ู€ macrophage ูˆุจุงู„ุชุงู„ูŠ ู‡ุฐุง

346
00:29:10,600 --> 00:29:17,140
ุจูŠุคุฏูŠ ุฅู„ู‰ pathological lesion ูˆrenal failure ุฃุณุฆู„ุฉ

347
00:29:17,140 --> 00:29:21,360
ูƒู…ุงู† ู…ู…ูƒู† ุชู†ุชุฌ ู†ุชูŠุฌุฉ ุงู„ู€ exposure to some common

348
00:29:21,360 --> 00:29:26,110
environmental factor ุฒูŠ ุงู„ู€ ultraviolet light ู‡ุฑู…ูˆู†

349
00:29:26,110 --> 00:29:30,050
ูˆุฅู†ููƒุณูŠูˆุฒ ุงูŠุฌุงู†ุฒ ูŠุนู†ูŠ ู…ุด ุชุนู…ู„ ุจู‚ู‰ ููŠุฑูˆุณ ูˆูƒู„ู‡ู… ุจู„ุนุจ

350
00:29:30,050 --> 00:29:38,710
ุฏูˆุฑ ููŠ ุงู„ู€ etiology of disease ูŠุนู†ูŠ

351
00:29:38,710 --> 00:29:44,670
you can cross react with nuclear antigen induction

352
00:29:44,670 --> 00:29:51,030
ุฃูŠุถุง by drugs ุฒูŠ ุงู„ู€ penicillamine ูƒู„ูˆุฑูˆ ุจุฑู…ุงุฒูŠู†

353
00:29:51,030 --> 00:29:57,110
ู‡ูŠุฏุฑุงุฒูŠู†ุงู„ุดูŠุก ุงู„ู„ูŠ ูŠุญุฏุซ ู‡ูˆ ุฃู† ู…ุตุงุฏุฑ ุงู„ุงู†ุชุฑู†ูƒู„ูŠุงุช

354
00:29:57,110 --> 00:30:01,430
ุชู†ุชุฌ ู…ุตุงุฏุฑ ุงู„ุงู†ุชุฑู†ูƒู„ูŠุงุช ู„ุดุฎุต ูˆุงุญุฏ.ููŠ ุงู„ุบุฑุจุŒ

355
00:30:01,430 --> 00:30:02,170
ุงู„ู…ุตุงุฏุฑ ุงู„ู„ูŠ ุชุฏูุนู‡ุง ู„ู„ู…ุตุงุฏุฑ ุงู„ู„ูŠ ุชุฏูุนู‡ุง ู„ู„ู…ุตุงุฏุฑ

356
00:30:02,170 --> 00:30:03,170
ุงู„ู„ูŠ ุชุฏูุนู‡ุง ู„ู„ู…ุตุงุฏุฑ ุงู„ู„ูŠ ุชุฏูุนู‡ุง ู„ู„ู…ุตุงุฏุฑ ุงู„ู„ูŠ

357
00:30:03,170 --> 00:30:06,790
ุชุฏูุนู‡ุง ู„ู„ู…ุตุงุฏุฑ ุงู„ู„ูŠ ุชุฏูุนู‡ุง ู„ู„ู…ุตุงุฏุฑ ุงู„ู„ูŠ ุชุฏูุนู‡ุง

358
00:30:06,790 --> 00:30:08,710
ู„ู„ู…ุตุงุฏุฑ ุงู„ู„ูŠ ุชุฏูุนู‡ุง ู„ู„ู…ุตุงุฏุฑ ุงู„ู„ูŠ ุชุฏูุนู‡ุง ู„ู„ู…ุตุงุฏุฑ

359
00:30:08,710 --> 00:30:12,710
ุงู„ู„ูŠ ุชุฏูุนู‡ุง ู„ู„ู…ุตุงุฏุฑ ุงู„ู„ูŠ ุชุฏูุนู‡ุง ู„ู„ู…ุตุงุฏุฑ ุงู„ู„ูŠ

360
00:30:12,710 --> 00:30:15,650
ุชุฏูุนู‡ุง ู„ู„ู…ุตุงุฏุฑ ุงู„ู„ูŠ ุชุฏูุนู‡ุง ู„ู„ู…ุตุงุฏุฑ ุงู„ู„ูŠ ุชุฏูุนู‡ุง

361
00:30:15,650 --> 00:30:21,690
ู„ู„ู…ุตุงุฏุฑ ุงู„ู„ูŠุจู†ุฌูŠ ู„ู†ูˆุน ุชุงู†ูŠ ู…ู† ุงู„ู€ autoimmune

362
00:30:21,690 --> 00:30:25,890
disease ุงู„ู„ูŠ ุจูŠูƒูˆู† ููŠ ุชูŠู„ูŠู†ููˆุณุงูŠุช ุงู„ุนุจุฏุงู„ูƒุจูŠุฑ in

363
00:30:25,890 --> 00:30:31,810
organ damage ูˆู†ุญูƒูŠ ุนู„ู‰ multiple sclerosis ููŠ ุงู„

364
00:30:31,810 --> 00:30:39,070
multiple sclerosis ุงู„ู„ูŠ ุจูŠุตูŠุฑ ููŠู‡ demyelination of

365
00:30:39,070 --> 00:30:45,050
central nervous system tissue ุจูŠู†ู‡ุฑูŠ

366
00:30:45,050 --> 00:30:52,600
ุงู„ู€ myelin sheath ูˆุงุญุฏุฉ ุจูŠู‚ุฏูŠ ุฅู„ูŠู‡ุง relapse or remitting

367
00:30:52,600 --> 00:30:57,600
or progressive paralytic course ูŠุนู†ูŠ ุจุญุตู„ู‡ุง ููŠ

368
00:30:57,600 --> 00:31:03,100
ุงู„ุบุงู„ุจ ุดู„ู„ ู„ู„ุจุฑูŠุฏ ู„ุฃู† ุงู„ู€ myelin sheath ู‡ูŠ

369
00:31:03,100 --> 00:31:10,380
ุงู„ู…ุณุฆูˆู„ุฉ ุนู† ุงู„ู€ neurotransmitter ู†ูŠุฑูˆ ุณูŠุฌุงู„ it's

370
00:31:10,380 --> 00:31:13,240
considered to be a T cell mediated autoimmune

371
00:31:13,240 --> 00:31:17,980
disease ูˆุงู„ู„ูŠ ุจูŠุตูŠุฑ ููŠ cellular infiltrate

372
00:31:17,980 --> 00:31:21,010
associated with T ุงู„ู€ protein ูˆุงู„ู†ูˆุน Delete type of

373
00:31:21,010 --> 00:31:27,490
sensitivity mechanism class two ุฃู…ุฏุดูŠ ู…ูˆู„ูŠูƒูŠูˆู„

374
00:31:27,490 --> 00:31:35,570
ุจูŠู„ุนุจ ุฏูˆุฑ ูƒุจูŠุฑ ููŠ ุงู„ู€ disease susceptibility ุงู„ุฑุงุจุท

375
00:31:35,570 --> 00:31:38,390
ูŠุนู†ูŠ ุงู„ู„ูŠ ู‡ูˆ type one insulin diabetes mellitus

376
00:31:38,390 --> 00:31:44,710
insulin dependent diabetes mellitus ู…ุฌุฑุฏ chronic

377
00:31:44,710 --> 00:31:48,670
inflammatory destruction of the beta cell

378
00:31:50,840 --> 00:31:55,160
ููŠ ุงู„ุจู†ูƒุฑูŠุงุณ ูˆู‡ูŠ ุนุจุงุฑุฉ ุนู† insulin producing beta

379
00:31:55,160 --> 00:32:02,060
islet cell of the ุจู†ูƒุฑูŠุงุณ ูˆุทุจุนุง ุงู„ู…ุณุฆูˆู„ ุงู„ู…ุจุงุดุฑ ููŠ

380
00:32:02,060 --> 00:32:05,340
ู‡ุฐุง ุงู„ู…ูˆุถูˆุน ู‡ูˆ cytotoxic T cell ุงู„ุชูŠ ุชูู‡ุงุฌู… ู‡ุฐู‡

381
00:32:05,340 --> 00:32:13,420
ุงู„ุฎู„ุงูŠุง ูˆุชููˆู„ุฏ cytokine ูˆุงู„ู…ู‡ูˆุก ุฃูŠุถู‹ุง ุจุชุคุฏูŠ ุฅู„ู‰

382
00:32:13,420 --> 00:32:18,080
antibody production ุชูู‡ุงุฌู… ุงู„ุฎู„ุงูŠุง

383
00:32:28,320 --> 00:32:34,580
ุงู„ู†ุณุจุฉ ู„ู€ HLA type HLA

384
00:32:34,580 --> 00:32:39,140
type HLA

385
00:32:39,140 --> 00:32:41,700
type HLA type HLA type HLA type

386
00:32:41,700 --> 00:32:41,980
HLA type HLA type HLA type HLA

387
00:32:41,980 --> 00:32:42,040
type HLA type HLA type HLA type

388
00:32:42,040 --> 00:32:42,240
HLA type HLA type HLA type HLA

389
00:32:42,240 --> 00:32:44,580
type HLA type HLA type HLA type ูŠูˆุฌุฏ ุฃู†

390
00:32:44,580 --> 00:32:47,880
50% ู…ู† Insulin Dependent ู…ุฑุถ ุงุณู…ู‡ latest

391
00:32:47,880 --> 00:32:54,320
patient ุนู†ุฏู‡ู… HLA-DR3 ุฃุฑุจุนุฉ ู‡ูŠุชูŠุฑูˆุฒุงูŠุฏุฒ positive ูˆ

392
00:32:54,320 --> 00:33:02,660
individuals with HLA-DQP1 ุงู„ุฐูŠ ู‡ูˆ 0602 rarely

393
00:33:02,660 --> 00:33:07,520
develop the disease Hashimoto's

394
00:33:07,520 --> 00:33:14,360
thyroiditis ู…ูˆุฌูˆุฏ ููŠ the middle aged women ูŠุคุฏูŠ ู„ู€

395
00:33:14,360 --> 00:33:20,140
Formation of Goiter ูˆุทุจุนุง ุงู„ู…ุญุตู„ุฉ Atrophy of the

396
00:33:20,140 --> 00:33:24,020
thyroid gland ุงู„ุฐูŠ ูŠุคุฏูŠ ููŠ ุงู„ู†ู‡ุงูŠุฉ ู„ู€

397
00:33:24,020 --> 00:33:27,400
Hypothyroidism and Destruction of the thyroid

398
00:33:27,400 --> 00:33:34,040
function ุบุงู„ุจุง ุงู„ู…ุฑุถ associated with T cell ู„ูƒู† ุงู„

399
00:33:34,040 --> 00:33:39,920
antibody ุชู„ุนุจ ุฏูˆุฑู‹ุง ูƒุจูŠุฑู‹ุง ููŠ ุงู„ู…ุฑุถ Target antigen

400
00:33:39,920 --> 00:33:44,190
include thyroglobulinุŒ ุงู„ู…ูŠูƒุฑูˆุฒูˆู…ุงู„ ุงู†ุชูŠุฌูŠู† ู…ู† ุงู„ู€

401
00:33:44,190 --> 00:33:48,530
Thyroid Epithelial CellุŒ ูˆ Antibodies of these antigens ุชู…

402
00:33:48,530 --> 00:33:55,450
ุงูƒุชุดุงูู‡ุง. Infiltration of B cell andonuclear B cell and 

403
00:33:55,450 --> 00:34:00,050
nuclear T cell and microfollicle ูŠุคุฏูŠ ุฅู„ู‰ ุงู„ุงู†ุชู‚ุงู„ ูˆุฅุฏู…ุงุฌ ู…ู†

404
00:34:00,050 --> 00:34:06,310
the thyroid follicle ูˆุจุงู„ุชุงู„ูŠ ุงู„ุบุฏุฉ ุชุญุงูˆู„ ุงู„ุงู†ุชู‚ุงู„

405
00:34:06,310 --> 00:34:11,640
ูˆุชุตุจุญ ูƒุจูŠุฑุฉ ุฑุฏ ูุนู„ ุทุจูŠุนูŠ ุฅู†ู‡ ุชุนู…ู„

406
00:34:11,640 --> 00:34:16,940
Regeneration ูˆุจุงู„ุชุงู„ูŠ ุชุจุฏุฃ ุชูƒุจุฑ when destruction

407
00:34:16,940 --> 00:34:23,380
continues Symptoms of hypothyroidism appear ู…ุซุงู„

408
00:34:23,380 --> 00:34:29,000
ุขุฎุฑ when one has arthritis chronically inflamed

409
00:34:29,000 --> 00:34:37,010
synovium ูˆูŠุตุจุญ ู…ุฒุฏุญู… ุจูƒุซุงูุฉ ู…ุน lymphocyte

410
00:34:37,010 --> 00:34:43,690
ู…ุญุตู„ุฉ destruction of the cartilage and bone ุทุจุนุง

411
00:34:43,690 --> 00:34:49,710
Synovium is densely packed with dendritic cell,

412
00:34:49,810 --> 00:34:53,890
macrophage, T cell, B cell, NK cell, and clumps of

413
00:34:53,890 --> 00:34:57,790
plasma cell ูˆููŠ ุจุนุถ ุงู„ุฃุญูŠุงู† ูŠุตุจุญ ููŠู‡ secondary

414
00:34:57,790 --> 00:35:04,620
follicle Pathology ู‡ูˆ ุนุจุงุฑุฉ ุนู† ู…ุญุตู„ุฉ

415
00:35:04,620 --> 00:35:08,240
ู„ู€ mixture of immunopathological mechanism ุฎุตูˆุตุง

416
00:35:08,240 --> 00:35:11,680
Immune Complexes Formation Complement

417
00:35:11,680 --> 00:35:16,610
Activity Polymorphic Nuclear Infiltration ูˆุงู„ู€

418
00:35:16,610 --> 00:35:21,230
inflammatory CD4 ูˆุงู„ู€ CD8 ูˆุงู„ู€ cytotoxic T

419
00:35:21,230 --> 00:35:25,870
-lymphocyte ู…ุน ุงู„ู€ activated macrophage ูˆุงู„ู€ unk

420
00:35:25,870 --> 00:35:29,890
cell ูˆุงู„ู€ cell-mediated immunity ูƒู„ู‡ุง ุงุจุชุฏุงู„ ุนู†

421
00:35:29,890 --> 00:35:30,150
ุฐู„ูƒ

422
00:35:35,260 --> 00:35:38,900
A variety of cytokines ูƒู„ู‡ู… ุนุจุงุฑุฉ ุนู† ุฎู„ุงูŠุง ู…ุจุทู†ุฉ

423
00:35:38,900 --> 00:35:43,020
ูƒู„ู‡ู… ูŠููุฑุฒูˆู† cytokine ุฃุดู‡ุฑ ู‡ุฐุง ุงู„ cytokine human

424
00:35:43,020 --> 00:35:47,720
necrosis factor alpha ูˆ IL-1 ูˆ degradative enzymes

425
00:35:47,720 --> 00:35:52,380
ูˆ ุจุนุถ ุงู„ mediators that destroy the integrity of

426
00:35:52,380 --> 00:35:57,840
cartilage Chondrocytes ุฎู„ุงูŠุง ุงู„ุบุถุฑูˆู ุทุจุนุง

427
00:35:57,840 --> 00:36:02,360
ุชุตุจุญ ู…ูƒุดูˆูุฉ ู„ู„ุฌู‡ุงุฒ ุงู„ู…ู†ุงุนูŠ ุณู†ูˆูŠุง ุงู„ูู„ูˆุฏ

428
00:36:02,360 --> 00:36:07,690
ููŠ ุงู„ุบุงู„ุจ ุชุชุฌู…ุน ููŠ ุฌุฏุงุฑ ุงู„ู€ Arthritis ุงู„ุฑูˆู…ุงุชูˆูŠุฉ

429
00:36:07,690 --> 00:36:13,330
ูˆูŠุญุชูˆูŠ ุนู„ู‰ ุนุฏุฏ ูƒุจูŠุฑ ู…ู† Polymorphic Nuclear Cell

430
00:36:13,330 --> 00:36:23,170
ูˆุงู„ููŠุจุฑูŠู†

431
00:36:23,170 --> 00:36:28,390
ุชู… ุชุฑุณูŠุจู‡ ูˆูŠุชู… ุชุฑุณูŠุจู‡ ุจุงู„ููŠุจุฑุงุณุชูŠุดูˆ ูˆุฌุฏุงุฑ

432
00:36:28,390 --> 00:36:30,290
ุงู„ุฃู†ูƒู„ูˆุฒ

433
00:36:36,600 --> 00:36:46,060
IgM ุฑูˆู…ุงุชูˆูŠุฏ ูุงูƒุชูˆุฑ ูŠุฑุชุจุท ุจุฌุฒุก Fc

434
00:36:46,060 --> 00:37:01,280
ู„ู€ IgG ุงู„ุทุจูŠุนูŠ ุนู„ู‰ ุฌุฒูŠุก IgG ุฑูˆู…ุงุชูˆูŠุฏ

435
00:37:01,280 --> 00:37:09,770
ูุงูƒุชูˆุฑ ู…ููŠุฏ of disease activity ูˆุบุงู„ุจุง

436
00:37:09,770 --> 00:37:15,590
ูˆุฌุฏูˆู‡ ูŠุตู„ ุฅู„ู‰ remission during ูŠุตุจุญ ููŠู‡ ู…ุณุชูˆู‰ ู…ู†ุฎูุถ

437
00:37:15,590 --> 00:37:22,270
during remission ู…ุซุงู„ ุงู„ุฃุฎูŠุฑ ุฃุธู† ุฃู† ุงู„ autoimmune

438
00:37:22,270 --> 00:37:28,620
disease ุงู„ุฐูŠ ู†ุงุชุฌ ุนู† ูƒู…ุจู„ู…ู†ุช ูƒู…ุจู„ู…ู†ุช ูƒู…ุจู„ู…ู†ุช

439
00:37:28,620 --> 00:37:33,700
ูƒู…ุจู„ู…ู†ุช ูƒู…ุจู„ู…ู†ุช ูƒู…ุจู„ู…ู†ุช ูƒู…ุจู„ู…ู†ุช ูƒู…ุจู„ู…ู†ุช ูƒู…ุจู„ู…ู†ุช

440
00:37:33,700 --> 00:37:35,840
ูƒู…ุจู„ู…ู†ุช ูƒู…ุจู„ู…ู†ุช ูƒู…ุจู„ู…ู†ุช ูƒู…ุจู„ู…ู†ุช ูƒู…ุจู„ู…ู†ุช ูƒู…ุจู„ู…ู†ุช

441
00:37:35,840 --> 00:37:41,820
ูƒู…ุจู„ู…ู†ุช ูƒู…ุจู„ู…ู†ุช ูƒู…ุจู„ู…ู†ุช ูƒู…ุจู„ู…ู†ุช ูƒู…ุจู„ู…ู†ุช ูƒู…ุจู„ู…ู†ุช

442
00:37:41,820 --> 00:37:41,880
ูƒู…ุจู„ู…ู†ุช ูƒู…ุจู„ู…ู†ุช ูƒู…ุจู„ู…ู†ุช ูƒู…ุจู„ู…ู†ุช ูƒู…ุจู„ู…ู†ุช ูƒู…ุจู„ู…ู†ุช

443
00:37:41,880 --> 00:37:42,360
ูƒู…ุจู„ู…ู†ุช ูƒู…ุจู„ู…ู†ุช ูƒู…ุจู„ู…ู†ุช ูƒู…ุจู„ู…ู†ุช ูƒู…ุจู„ู…ู†ุช ูƒู…ุจู„ู…ู†ุช

444
00:37:42,360 --> 00:37:51,720
ูƒู…ุจู„ู…ู†ุช ูƒู…ุจู„ู…ู†ุช ูƒู…ุจู„ู…ู†ุช ูƒู…ุจู„ู…ู†ุช ูƒู…ุจู„ู…ู†ุช ูƒู…ุจู„ู…ู†ุช

445
00:37:51,950 --> 00:37:55,510
Complement Clearance Mechanism as in Serum

446
00:37:55,510 --> 00:38:00,750
Sickness ูŠุนู†ูŠ ู„ุง ูŠุตู„ู‡ุง Clearance Deficiency in

447
00:38:00,750 --> 00:38:06,190
complement 4 ูŠู‚ุตุฏ ุซู„ุงุซุฉ ูŠุคุฏูŠ ู„ู€ ุงู„ูุดู„ to clear

448
00:38:06,190 --> 00:38:11,770
immune complexes by macrophage ุฃุณุฃู„ ู…ุงุฐุง ูŠุญุฏุซ ุฃูƒุซุฑ

449
00:38:11,770 --> 00:38:14,530
ู…ู† 80% ู…ู† ุงู„ุฃูุฑุงุฏ ุนู†ุฏู‡ู… complement

450
00:38:14,530 --> 00:38:17,930
deficiency of C1 ูˆC4 ูˆC2

451
00:38:21,850 --> 00:38:26,150
Therapeutic Strategies ู…ุงุฐุง ูŠูุนู„ูˆู† ููŠ ู‡ุฐู‡ ุงู„ุญุงู„ุฉุŸ ูŠูุนู„ูˆู†

452
00:38:26,150 --> 00:38:29,470
Cytotoxic Drugs ู…ุซู„ ุงู„ู€ cyclophosphamide ูˆุงู„ู€

453
00:38:29,470 --> 00:38:36,060
azathioprine ู‡ุคู„ุงุก ูŠูู‡ุงุฌู…ูˆู† DNA Replication ูˆูŠูู‡ุงุฌู…ูˆู†

454
00:38:36,060 --> 00:38:43,780
ุจุดูƒู„ ุฃุณุฑุน ุฌุณู… ุงู„ุจุทุงู„ุฉ ุจุดูƒู„ ุฃุณุฑุน ุจุดูƒู„ ุฃุณุฑุน ุจุดูƒู„

455
00:38:43,780 --> 00:38:44,420
ุฃุณุฑุน ุจุดูƒู„ ุฃุณุฑุน ุจุดูƒู„ ุฃุณุฑุน ุจุดูƒู„ ุฃุณุฑุน ุจุดูƒู„ ุฃุณุฑุน ุจุดูƒู„

456
00:38:44,420 --> 00:38:47,100
ุฃุณุฑุน ุจุดูƒู„ ุฃุณุฑุน ุจุดูƒู„ ุฃุณุฑุน ุจุดูƒู„ ุฃุณุฑุน ุจุดูƒู„ ุฃุณุฑุน ุจุดูƒู„

457
00:38:47,100 --> 00:38:47,140
ุฃุณุฑุน ุจุดูƒู„ ุฃุณุฑุน ุจุดูƒู„ ุฃุณุฑุน ุจุดูƒู„ ุฃุณุฑุน ุจุดูƒู„ ุฃุณุฑุน ุจุดูƒู„

458
00:38:47,140 --> 00:38:47,220
ุฃุณุฑุน ุจุดูƒู„ ุฃุณุฑุน ุจุดูƒู„ ุฃุณุฑุน ุจุดูƒู„ ุฃุณุฑุน ุจุดูƒู„ ุฃุณุฑุน ุจุดูƒู„

459
00:38:47,220 --> 00:38:55,540
ุฃุณุฑุน ุจุดูƒู„ ุฃุณุฑุน ุจุดูƒู„ ุฃุณุฑุน ุจุดูƒู„ ุฃุณุฑุน ุจุดูƒู„

460
00:38:55,540 --> 00:39:02,200
Anti Cytokine Therapy ุจู„ู‚ ุฃูˆ tumor necrosis factor

461
00:39:02,200 --> 00:39:06,060
alpha by antibody or soluble receptor for

462
00:39:06,060 --> 00:39:10,580
rheumatoid arthritis. Inhibition of IL-1 beta by

463
00:39:10,580 --> 00:39:16,360
soluble receptor also seems a useful strategy in

464
00:39:16,360 --> 00:39:22,280
rheumatoid arthritis. These immunomodulatory agents

465
00:39:23,780 --> 00:39:27,020
ุชูู…ู†ุญู†ุง ุงู†ูู„ุงู…ุงุช ุฑุฏูˆุฏ ุทุจุนุง ุฅุฐุง ุนู…ู„ู†ุง Blockage

466
00:39:27,020 --> 00:39:33,680
ู„ู€ IL-1 beta ู†ูˆู‚ู ู†ุดุงุทู‡ interferon beta ู‡ูˆ

467
00:39:33,680 --> 00:39:38,400
ูŠุณุชุฎุฏู… ู„ู„ุชุนุงู…ู„ ู…ุน ุงู„ุชุตู„ุจ ุงู„ู…ุชุนุฏุฏ ู…ู† ุฎู„ุงู„

468
00:39:38,400 --> 00:39:44,820
ุงู„ู€ antibody ุฅู„ู‰ CD3 ุจุฑุถู‡ ูุญุตูˆู‡ ุฌูŠุฏู‹ุง ููŠ ุงู„

469
00:39:44,820 --> 00:39:51,180
autoimmune diabetes Costimulatory Blockade ู…ุซู„ ุงู„

470
00:39:52,450 --> 00:39:56,170
ุทุจุนุง CTLA-4 ูˆ Blockade ุชุธู‡ุฑ

471
00:39:56,170 --> 00:40:00,830
promising ููŠ rheumatoid arthritis and psoriasis ุจู„ุทู‚

472
00:40:00,830 --> 00:40:06,610
ุจุจุชูŠุฏุงุช that bind to MHC group but not capable of

473
00:40:06,610 --> 00:40:11,230
activating a given T cell have been used to induce

474
00:40:11,230 --> 00:40:17,010
tolerance in rodent models ูŠุนู†ูŠ ุฃุฏุฎู„ูˆุง ุจุจุชูŠุฏ ุชุฑุชุจุท

475
00:40:17,010 --> 00:40:20,590
ุจุงู„ู€ MHC molecule ูˆุจุงู„ุชุงู„ูŠ ุฎู„ุงุต ู…ุดุบูˆู„ ู…ุง ููŠุด

476
00:40:20,590 --> 00:40:26,190
ุฅู…ูƒุงู†ูŠุฉ ุฃู†ู‡ ุชุนู…ู„ ุงู„ุฎู„ุงูŠุง ุชุนู…ู„ Antigen Presentation

477
00:40:26,190 --> 00:40:31,410
T cell receptor have been administered to patients

478
00:40:31,410 --> 00:40:38,310
as an immunogen in an effort to raise a clonotype

479
00:40:38,310 --> 00:40:41,270
specific cytotoxic T cell

480
00:40:44,980 --> 00:40:52,700
ูŠุนู†ูŠ ู‡ู†ุง ุฃุฏุฎู„ูˆุง Receptor ูˆุญุตู„ุช ุนู„ู‰ ุงุนุชุจุงุฑ ุงู„ุฌุณู…

481
00:40:52,700 --> 00:40:57,220
ูƒู…ุณุชุถุฏ ูˆุทุจุนุง ู†ุดุฑุช ู„ู†ุง site toxic T lymphocyte

482
00:40:57,220 --> 00:41:02,900
ุงู„ุชูŠ ุนู…ู„ุช destruction ู„ู„ุฎู„ุงูŠุง generation of T

483
00:41:02,900 --> 00:41:07,460
suppressor cell in autoimmune individuals ุจุฑุถู‡ ู‡ุฐุง

484
00:41:07,460 --> 00:41:14,350
ุนุจุงุฑุฉ ุนู† ุนู„ุงุฌ ุทุจุนุง ู‡ูŠ ุงู„ autoimmune disease ูˆุงู„ู€

485
00:41:14,350 --> 00:41:20,030
MHC association with which ุงู„ุฃู„ูŠู„ commonly found

486
00:41:20,030 --> 00:41:25,830
strength of association ุงู„ุนู„ุงู‚ุฉ ุจูŠู† ุงู„ุฃู…ุฑุงุถ ูˆุงู„ู€

487
00:41:25,830 --> 00:41:31,610
MHC ุฌูŠู† ูˆุงู„ุฃู„ูŠู„ ุงู„ุชูŠ ุชูƒูˆู† ู…ูˆุฌูˆุฏุฉ ุทุจุนุง ู‡ุฐุง ุนู„ุงู‚ุฉ

488
00:41:31,610 --> 00:41:38,010
ู…ูƒุชูˆุจุฉ strength ุฃูˆ weak ูŠุนู†ูŠ ูˆุฌูˆุฏ ุงู„ุฃู„ูŠู„ ุงู„ุชูŠ ุชุจุน

489
00:41:38,010 --> 00:41:44,660
ุงู„ู€ MHC molecule ู…ุงุดูŠ ุจู‡ุฐู‡ ุงู„ุงู‚ุงู…ุจูŠุคุฏูŠ ุฅู„ู‰ ุฃู†

490
00:41:44,660 --> 00:41:49,040
ุงู„ู…ุฑุถ ูŠุตุจุญ high risk of age inducing such diseases

491
00:41:49,040 --> 00:41:54,740
ุฃู†ุง

492
00:41:54,740 --> 00:41:57,780
ุงู„ autoimmune disease ูˆุงู„ auto antigen ุงู„ุชูŠ

493
00:41:57,780 --> 00:42:05,920
ูŠูุณู…ู‰ ู…ู‡ุงุฌู…ุฉ ูˆู…ูŽู† ุงู„ุฐูŠ ูŠูู‡ุงุฌู… ู…ูŽู†

494
00:42:05,920 --> 00:42:14,640
ุงู„ุฐูŠ ูŠูู‡ุงุฌู… ูˆุจู‡ุฐุง ู†ูƒูˆู† ู‚ุฏ ุฃู†ู‡ูŠู†ุง ุงู„ู…ุญุงุถุฑุฉ ุดูƒุฑู‹ุง

495
00:42:14,640 --> 00:42:15,480
ุจุงู„ู…ุชุงุจุนุฉ